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ABSTRACT OF DISSERTATION 
 
 
 
          
TGF-β, WNT, AND FGF  
SIGNALING PATHWAYS DURING AXOLOTL TAIL REGENERATION  
AND FORELIMB BUD DEVELOPMENT 
 
 
Tgf-β, Wnt, and Fgf signaling pathways are required for many developmental 
processes. Here, I investigated the requirement of these signaling pathways during tail 
regeneration and limb development in the Mexican axolotl (Ambystoma mexicanum).  
 
Using small chemical inhibitors during tail regeneration, I found that the Tgf-β 
signaling pathway was required from 0-24 and 48-72 hours post tail amputation (hpa), 
the Wnt signaling pathway was required from 0-120 hpa, and the Fgf signaling 
pathway was required from 0-12hpa. Tgf-β1 was upregulated after amputation and 
thus may mediate Tgf-β signaling pathway during tail regeneration. Both Smad-
mediated and non-Smad mediated Tgf-β signaling were activated as early as 1hpa. 
Smad-mediated Tgf-β signaling via activated pSmad2 and pSmad3, and via 
phosphorylated Erk and Akt. Two different Tgf-β signaling pathway inhibitors, 
SB505124 and Naringenin, differentially regulated pSmad2, pSmad3, p-Erk, and p-
Akt, while SB505124 and Naringenin both inhibited tail regeneration; only SB505124 
reduced cell proliferation. Wnt/β-Catenin signaling was increased and was enhanced 
by Wnt-C59. Disruption of the Wnt signaling pathway directly or indirectly activated 
Erk and Akt signaling. Disruption of the Fgf signaling pathway decreased p-Erk and 
increased p-Akt. All three signaling pathways affected cell proliferation and mitosis 
during tail regeneration.  
 
The Wnt pathway inhibitor Wnt-C59 prevented forelimb bud outgrowth. The critical 
window for Wnt signaling regulating forelimb bud outgrowth was approximately 
developmental stage 40-42. Wnt signaling ligand Wnt3a and tight junction protein 
Zo-1 were expressed in the epidermis of the forelimb bud and both were down-
regulated by Wnt-C59. Moreover, both Wnt and Fgf signaling pathways affected cell 
proliferation and mitosis of mesodermal cells during forelimb bud outgrowth.  
 
Overall, my results show that Tgf-β, Wnt, and Fgf signaling pathways are required for 
axolotl tail regeneration. All three pathways affect Erk and Akt signaling and guide 
cell proliferation and mitosis. The Wnt signaling pathway is required for forelimb bud 
outgrowth, and it appears to regulate expression of Wnt3a and Zo1, and control cell  
 
 
 
proliferation and mitosis of mesodermal cells underlying the forelimb epidermis. 
These data enrich understanding of signaling network dynamics that underlie tissue 
regeneration and vertebrate limb development.  
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CHAPTER 1: INTRODUCTION 
Qingchao Qiu1 
1Department of Neuroscience, University of Kentucky, Lexington, Kentucky 
KEYWORDS: Tgf-β, Wnt, Fgf, regeneration, limb development 
1.1 Preface 
How organisms regenerate body parts is not entirely understood. Using genetic and 
pharmaceutical methods, several signaling pathways have been shown to play 
essential roles during tissue regeneration. In this chapter, I review the Transforming 
growth factor beta (Tgf-β), Wingless/Integrated (Wnt), and Fibroblast growth factor 
(Fgf) signaling pathways in regulating wound epithelium formation, blastema 
formation, and cell proliferation during tissue regeneration. I also review Wnt and Fgf 
signaling pathways during limb development. Understanding signaling pathway 
dynamics during tissue regeneration and embryonic development may shed light on 
mechanisms of tissue regeneration and suggest therapeutic strategies to enhance 
regenerative ability in mammals.  
 
1.2 Tissue regeneration 
1.2.1 Cellular basis of tissue regeneration in animals 
In recent years, cell lineage tracing and transplantation studies have identified 
progenitor cell populations that orchestrate tissue regeneration responses in many 
classical model organisms (Tanaka and Reddien 2011; Cary et al. 2019; Fink, 
Andersson-Rolf, and Koo 2015). Planaria regenerate an entire body from a tiny body 
fragment with pluripotent stem cells called clonogenic neoblasts (Wagner, Wang, and 
Reddien 2011; Scimone et al. 2014). A small body fragment of Hydra regenerates an 
individual similar to the original through ectodermal and endodermal epithelial stem 
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cells and interstitial stem cells (Bosch 2007; Govindasamy, Murthy, and Ghanekar 
2014). Axolotl appendages and Xenopus tails harbor tissue and germ layer restricted 
progenitors that are recruited to form a regeneration blastema (Tanaka and Reddien 
2011; Bryant, Endo, and Gardiner 2002; Gargioli and Slack 2004; Mochii, Taniguchi, 
and Shikata 2007). For example, axolotl Schwann cells regenerate from Schwann 
cells only, progenitor cells in muscle regenerate muscle, and progenitor cells in 
cartilage regenerates cartilage. In contrast, dermal cells regenerate dermis, connective 
tissue, and cartilage in a germ layer-specific manner  (Kragl et al. 2009). These 
lineage tracing studies provide valuable information for understanding the cellular 
basis of tissue regeneration. How signaling pathways control these cellular behaviors 
during tissue regeneration is poorly understood. 
 
1.2.2 Signaling pathways and tissue regeneration in vertebrates  
Salamanders regenerate many body parts such as limb, tail, lens, heart, spinal cord, 
and brain (Sugiura et al. 2016; Nacu et al. 2016; Franklin, Voss, and Osborn 2017; 
Suetsugu-Maki et al. 2012; Nakamura et al. 2016; Tazaki, Tanaka, and Fei 2017; 
Amamoto et al. 2016). Upon limb amputation, epithelial cells migrate to the exposed 
wound surface and form a wound epithelium (Carlson, Bryant, and Gardiner 1998; 
Nye et al. 2003; Satoh et al. 2008). This wound epithelium thickens and matures into 
a signaling center that is called the Apical Epithelial Cap (AEC) (Christensen and 
Tassava 2000). Interactions between the AEC and underlying cells in the stump are 
considered to activate and support the proliferating undifferentiated blastemal cells, of 
which the majority are thought to be connective tissue cells (Satoh, Bryant, and 
Gardiner 2012). Multiple signaling pathways, including Tgf-β, Wnt, and Fgf signaling 
pathways are known to be deployed during tissue regeneration to regulate cellular and 
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developmental processes associated with tissue repair and the formation of new 
tissues (Ho and Whitman 2008; Singh et al. 2018; Peiris et al. 2016; Herman et al. 
2018). Detailing where and when signaling pathways are deployed during 
regeneration is essential to understanding how regeneration programs are regulated. 
  
1.2.3 The axolotl embryo tail regeneration model is an excellent animal model to use 
small molecule inhibitors to perturb and study signaling pathways associated with 
tissue regeneration.  
It is through the perturbation of signaling pathways that we learn about their necessity 
and requirement for regeneration. The axolotl assay uses hatching stage 42 embryos 
(Ponomareva et al. 2015) that are capable of regenerating amputated distal tail tips in 
7 days. Although axolotl limb regeneration has been studied most, it is not well suited 
for signaling pathway analysis. First, it takes several months for a fully developed 
limb to form. Second, the size of an axolotl with fully developed limbs is too large for 
the whole body, chemical treatment. Third, it takes about 40-50 days for a juvenile 
axolotl to regenerate a limb and even longer time for post-metamorphic adult axolotls 
to regenerate their limbs (Young, Bailey, and Dalley 1983). In contrast, the axolotl 
embryo tail regeneration model has several advantages for studying cell signaling 
pathways. First, hatching stage embryos have well-developed tails in less than 30 
days. Second, the size of the hatching stage embryo is about 1cm long, allowing them 
to be reared individually in 12-well, microtiter plates with small volumes of chemical 
solution. Third, a hatching stage embryo is capable of regenerating 2mm of the distal 
amputated tail in 7 days. Fourth, the endpoint of the experiment is an easy to score, 
morphological difference in body length, fin width, and fin shape. Fifth, chemicals 
can be directly dissolved in embryo rearing water to study molecular events during 
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tail regeneration. Lastly, axolotl embryo development is slow, allowing higher 
temporal resolution of molecular and cellular events that overlap in rapidly growing 
model organisms like Danio rerio (zebrafish) and Xenopus laevis (Xenopus). Axolotl 
embryos are also good to use for limb development studies, which will be discussed 
later. 
 
1.3 Tgf-β signaling pathway and tissue regeneration 
1.3.1 Tgf-β signaling pathway 
The Tgf-β signaling pathway has been well characterized in many species and cell 
culture studies. The Tgf-β signaling pathway is mediated by multiple ligands and 
receptors (Wrana et al. 1992; Attisano et al. 1993; Zhang et al. 1996). In general, Tgf-
β, Activin or Nodal bind with Tgf-β type II receptors on the cell membrane, causing 
the recruitment and transphosphorylation of Tgf-β type I receptors, Alk5, Alk4, and 
Alk7 (DaCosta Byfield et al. 2004). Activated Tgf-β type I receptors phosphorylate 
Smad2 and Smad3, which then interact with Smad4, a co-Smad that mediates 
translocation into the nucleus. The Smad2/Smad3/Smad4 complex binds specific 
DNA motifs to regulate transcription through various co-activator or co-repressor 
proteins (Derynck and Zhang 2003). Therefore, phosphorylated Smad2 and Smad3 
are essential transcription factors in Smad-mediated Tgf-β signaling pathways. On the 
other hand, non-Smad-mediated Tgf-β signaling pathway can be activated by 
phosphorylating extracellular-signal-regulated kinase (Erk) and Akt signaling 
pathways (Zhang 2009). Erk and Akt signaling are central cassettes of the mitogen-
activated protein kinase (Mapk) signaling pathway that regulates wound contraction 
and cell proliferation during Xenopus embryonic wound healing (Shaul and Seger 
2007; Li et al. 2013; Li et al. 2016). Tgf-β signaling also rapidly activates Akt 
signaling. Akt signaling is essential in regulating neoblast behavior and mediates 
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injury-mediated cell death during planarian tissue regeneration (Peiris et al. 2016). 
Down-regulation of Akt function by RNAi increased cell death throughout the body 
of a planarian (Peiris et al. 2016). 
 
1.3.2 Tgf-β signaling pathway inhibitor SB505124 
SB505124 is a selective and specific inhibitor for Tgf-β Type I receptors Alk4, Alk5, 
and Alk7, but not Alk1, Alk2, Alk3, and Alk6 (DaCosta Byfield et al. 2004). Treating 
cells with Tgf-β1 or Activin leads to phosphorylation of Alk5 and Alk4, respectively, 
which activate their downstream substrates Smad2 and Smad3 (DaCosta Byfield et al. 
2004), while BMP treated cells result in phosphorylation of Alk1, Alk2, Alk3, and 
Alk6, which then enable phosphorylation of Smad1, 5, and 8 (Heldin, Miyazono, and 
ten Dijke 1997). Alk7 mediates signaling by Nodal, another member of the Tgf-β 
superfamily. SB505124 has been developed initially as a competitive inhibitor of 
Alk5 by binding its ATP binding site, but it also inhibits Alk4 and Alk7. It is more 
potent and less toxic than a related Alk5 inhibitor SB431542 (DaCosta Byfield et al. 
2004). Therefore, SB505124 provides a valuable small molecule for perturbing the 
Tgf-β signaling pathway. In chapter 2, I used SB505124 to disrupt the Tgf-β signaling 
pathway during axolotl tail regeneration.  
 
1.3.3 Tgf-β signaling pathway inhibitor Naringenin  
Naringenin has been described as a pSmad3 inhibitor. It is the most abundant natural 
component from grapefruit and related citrus (Guengerich and Kim 1990). 
Interestingly, it was not shown to inhibit axolotl limb regeneration (Denis et al. 2016). 
In chapter 2, I used Naringenin to evaluate its effects on inhibiting phosphorylation of 
Smad3 during axolotl tail regeneration. 
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1.3.4 Tgf-β signaling during tissue regeneration  
The full nucleotide sequence of Tgf-β1 has been cloned, and three Tgf-β receptors, 
Tgf-β receptor I, II, and III have been identified in axolotl tissues. Tgf-β1 expression 
is strongly upregulated at 6hpa and maintained throughout axolotl limb regeneration 
(Denis et al. 2016; Levesque et al. 2007). Tgf-β2 is upregulated at 4hpa and Tgf-β5 is 
up-regulated at 2hpa during Xenopus tail regeneration (Ho and Whitman 2008). 
During lizard tail regeneration, activin-βA is strongly upregulated during the early 
stages of regeneration (Gilbert, Vickaryous, and Viloria-Petit 2013). Morpholino 
knockdown of activin-βA or its receptor Alk4 impairs zebrafish fin regeneration by 
affecting the migration of wound epithelial cells and formation of the blastema 
(Jazwinska, Badakov, and Keating 2007). The Tgf-β signaling pathway is also 
implicated in early wound healing processes during Xenopus tail regeneration (Ho 
and Whitman 2008). Both Tgf-β/Smad and Tgf-β/p38/Jnk pathways play roles in 
wound epithelial formation by affecting wound closure, which is associated with 
changes in the expression of epithelium mesenchymal transition markers Slug, Zeb2, 
Twist3, Vimentin, and N-cadherin (Sader et al. 2019). Tgf-β signaling also plays an 
important role in regulating the cell proliferation response during tissue regeneration. 
SB431542 inhibition of Tgf-β signaling pathway for seven days and 14 days 
irreversibly prevented limb regeneration by downregulating blastemal cell 
proliferation during axolotl limb regeneration (Levesque et al. 2007). Similarly, 
chemical inhibition of Tgf-β in the Xenopus tadpole tail model blocked blastema cell 
proliferation (Ho and Whitman, 2008). 
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The Tgf-β signaling pathway regulates the transcription, translation, and post-
translation modification of target genes through phosphorylation of Smad2 and 
Smad3 (Christensen and Tassava 2000; Chablais and Jazwinska 2012; Denis et al. 
2016). P-Smad2, but not p-Smad3 is required in axolotl limb regeneration (Denis et 
al. 2016). Activation of Smad3 via Tgf-β/activin signaling pathway is essential for the 
formation of a transient scar that is permissive for zebrafish heart regeneration 
(Chablais and Jazwinska 2012). P-Smad2 is also expressed at 6 hpa in the Xenopus 
laevis tadpole tail and SB431542 inhibition of Tgf-β signaling reduced p-Smad2 
expression during Xenopus tail regeneration (Sato, Umesono, and Mochii 2018). A 
Tgf-β signaling pathway target gene, fibronectin, is strongly expressed in the basal 
layer of the AEC (Christensen and Tassava 2000). Inhibition of the Tgf-β signaling 
pathway by SB431542 reduced fibronectin expression and blocked blastema 
formation during axolotl limb regeneration (Levesque et al. 2007). A proteomic study 
using regenerating axolotl limbs presented a model wherein Tgf-β and fibronectin 
activate transcription factors Sp1 and c-Myc, respectively, which potentially play 
essential roles during axolotl limb regeneration (Jhamb et al. 2011). The Tgf-β 
signaling pathway also activates non-Smad mediated signaling via Erk during 
Xenopus tadpoles tail regeneration (Ho and Whitman 2008). Thus, in the axolotl limb 
and Xenopus tail regeneration models, Tgf-β signals through both Smad-mediated and 
non-Smad mediated signaling pathways. However, it is unknown if Smad-mediated 
and non-Smad-mediated Tgf-β signaling regulates essential processes during axolotl 
tail regeneration. In chapter 2, I present data showing that Smad-mediated and non-
Smad mediated signaling regulate cell mitosis and cell proliferation during axolotl tail 
regeneration. 
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1.4 Wnt signaling pathway and tissue regeneration 
1.4.1 Wnt signaling pathway  
The central logic of the Wnt signaling pathway has emerged from three decades of 
study. Wnt proteins are conserved, secreted signaling molecules that play a myriad of 
biological roles in controlling developmental processes (Willert and Nusse 2012). 
Multiple cytoplasmic, nuclear, and extracellular components modulate Wnt signaling 
(Nusse 2005). There are 19 Wnt genes found in human and the mouse. The Xenopus 
tropicalis genome contains orthologues of all 19 mammalian Wnt genes (Yang 2003). 
Wnt protein binds the N-terminal extracellular cysteine-rich domain of a seven 
transmembrane molecule Frizzled (Fz) family receptor, alongside interactions with 
co-receptors including lipoprotein receptor-related (Lrp)5/6, Ror2 and receptor 
tyrosine kinase (Rtk) (Komiya and Habas 2008). Upon activation of the receptor, the 
Fz directly binds to Dsh which has three conserved protein domains: a central PDZ 
domain, an amino-terminal DIX domain, and a carboxy-terminal DEP domain (Wong 
et al. 2003). It is through the three domains of Dsh that canonical Wnt/β-Catenin, and 
non-canonical planar cell and calcium Wnt signaling, are accomplished (Habas and 
Dawid 2005).  
 
In the absence of Wnt ligand, cytoplasmic β-Catenin is degraded continuously by the 
action of a destruction complex composed of scaffolding protein Axin, the 
adenomatous polyposis coli gene product Apc, glycogen synthase kinase 3 (Gsk3), 
protein phosphatase 2A (Pp2A), and casein kinase 1.  Upon activation of Dsh through 
phosphorylation, DIX and PDZ domains of Dsh inhibit activity of Gsk3 in the 
destruction complex and lower the activity of the destruction complex (MacDonald, 
Tamai et al. 2009, Minde, Anvarian et al. 2011). The consequence of the low the 
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activity of destruction complex leads to accumulation and stabilization of the β-
Catenin protein. The β-Catenin translocates into the nucleus and acts as a coactivator 
of Tcf/Lef family transcription factors (Minde et al. 2013; Minde et al. 2011; 
MacDonald, Tamai, and He 2009).  
 
The non-canonical Wnt pathways are independent of β-Catenin. The noncanonical 
Wnt/PCP pathways use the PDZ and DIX domains of Dsh binding to Dishevelled-
associated activator of morphogeneis1(DAAM1) and activate the G-protein Rho 
(MacDonald, Tamai, and He 2009). Rho activates Rho-associated kinase (Rock) and 
regulates the cytoskeleton (Amano, Nakayama, and Kaibuchi 2010). Dsh also binds to 
Rac1 to mediate profilin binding to actin, which activates Jnk and affects actin 
polymerization (Spiering and Hodgson 2011).  
 
In the noncanonical Wnt/calcium pathways, Fz recruits Dsh through PDZ and DEP 
domains and directly interacts with a trimeric G-protein (MacDonald and He 2012). 
This co-stimulation of Dsh and G-protein leads to activation of either PLC, which 
promotes calcium release, or cGMP-specific PDE, which inhibits calcium release 
from the ER (Thakur et al. 2016). The Wnt/Calcium signaling pathway regulates 
many processes during development, including convergent extension movement, 
dorsoventral polarity, and organ formation (Lin et al. 2010; Freisinger, Fisher, and 
Slusarski 2010). 
 
1.4.2 Porcupine inhibitor Wnt-C59  
Wnt proteins are modified by palmitoylation. Palmitoylation is a hydrophobic 
modification of a conserved cysteine reside that affects Wnt protein transport and 
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distribution (Kurayoshi et al. 2007; Zhai, Chaturvedi, and Cumberledge 2004). Wnt 
proteins treated with enzyme acyl protein thioesterase are not hydrophobic or active, 
thus establishing that palmitate is essential for Wnt signaling (Nusse 2005). Studies in 
Drosophila and vertebrates have shown that Wnt palmitoylation is controlled by a 
membrane-bound O-acyl transferase called Porcupine, which is critical for generating 
Wnt secretion and gradients. Lack of Porcupine activity produces a phenotype similar 
to those of the Wg mutant in Drosophila (Medina, Taylor, and Donovan 1997). 
During chick neural tube development, Porcupine-mediated lipid modification 
reduces the activity of Wnt1 and Wnt3a (Galli et al. 2007). These studies show that by 
blocking Porcupine activity, Wnt secretion and activity is decreased. A Porcupine 
inhibitor, Wnt-C59, was used to block Wnt signaling during tail regeneration in 
chapter 3 and axolotl forelimb bud outgrowth in chapter 5. My results show that Wnt 
signaling is required for tail regeneration and limb development. 
 
1.4.3 Wnt signaling pathway during tissue regeneration 
The Wnt signaling pathway controls many tissue regeneration processes (Kawakami 
et al. 2006; Ghosh et al. 2008; Shimokawa et al. 2013; Hamilton, Sun, and Henry 
2016; Yokoyama et al. 2011; Sugiura et al. 2009; Lin and Slack 2008). In non-
vertebrates, Wnt/β-Catenin signaling pathway defines anteroposterior identity during 
regeneration. Upon depletion of β-Catenin, an amputated planarian tail regenerates 
into a head instead of a tail, and this leads to the generation of multiple heads 
suggesting that β-Catenin maintains anteroposterior identity during homeostasis and 
regeneration in planarians (Petersen and Reddien 2008; Gurley, Rink, and Sanchez 
Alvarado 2008). In Hydra, Wnt3a is expressed at the tip of the head of an intact 
animal and is rapidly re-expressed in head regenerate tips after amputation through 
13  
 
triggering an autocatalytic feedback loop (Hobmayer et al. 2000; Nakamura et al. 
2011). Knock down of Sp5, a transcriptional repressor of Wnt3, yields a robust multi-
headed phenotype after head amputation in Hydra (Nakamura et al. 2011). Beane et, 
al (2012) used RNAi to target components of the PCP pathway in planarian to 
dysregulate visual neuronal cell growth. Their findings suggest that PCP signaling is 
required to halt neuronal growth after the completion of tissue patterning during 
planarian regeneration. Both canonical and non-canonical Wnt signaling pathways are 
also involved in vertebrate tissue regeneration. Wnt-7a is expressed throughout 
axolotl limb regeneration (Shimokawa et al. 2013). Inhibiting the Wnt/β-Catenin 
signaling pathway prevents limb regeneration in axolotl larvae and fin regeneration in 
zebrafish by inducing alterations in the formation of the AEC that associated with the 
spatiotemporal regulation of p63 (Kawakami et al. 2006). β-Catenin overexpression 
induces limb regeneration in non-regeneration competent pre-apical ectodermal ridge 
(AER) chick embryos; in contrast, overexpression of p63 does not induce 
regeneration (Kawakami et al. 2006). The non-canonical Wnt signaling pathway is 
also crucial to regulate tissue regeneration. Overexpression of Wn5a during Xenopus 
tail regeneration induces ectopic larval tails at the injury site, presumably by altering 
JNK signaling (Sugiura et al. 2009). Interestingly, not only does blocking Wnt protein 
secretion and activity by Wnt-C59 prevent axolotl tail regeneration, but also 
activation of Wnt signaling by Wnt agonists differentially impairs axolotl limb 
regeneration, and prevents Xenopus cornea-lens regeneration and newt Wolffian-lens 
regeneration (Wischin et al. 2017; Hamilton, Sun, and Henry 2016). Suppression of 
Wnt/β-Catenin signaling is required for Xenopus limb regeneration and cornea-lens 
regeneration (Yokoyama et al. 2011; Hamilton, Sun, and Henry 2016). These findings 
suggest that Wnt/β-Catenin signaling is temporally regulated during regeneration. 
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Wnt ligands have opposing effects on β-Catenin and tissue regeneration (Stoick-
Cooper et al. 2007). Generally, Wnt3a stabilizes β-Catenin and mediates canonical 
Wnt/β-Catenin signaling (Hino et al. 2003). Noncanonical Wnt signaling pathway is 
independent of β-Catenin and is mediated by Wnt5a. However, it is reported that 
Wnt5a promotes Gsk-3-independent β-Catenin degradation and inhibits the canonical 
Wnt pathway (Topol et al. 2003). Therefore, Wnt5a is regarded as a link between 
canonical and non-canonical Wnt signaling. Ponomareva et al (2015) used both 
inhibitors and agonists to disrupt Wnt signaling pathway during axolotl tail 
regeneration. They found that Wnt antagonist IWR-1-end, Porcupine inhibitor Wnt-
C59, and Wnt agonist II SKL blocked axolotl tail regeneration (Ponomareva et al. 
2015). Transcriptional data showed that Wnt-C59 treatment affected transcription of 
genes associated with Wnt, Fgf, Tgf-β, Hox, Egf, Myc, Notch, Ngf, Ras/Mapk, p53, 
and retinoic acid (RA) pathways. Thus, Wnt signaling, via the transcriptional 
regulation of key target genes, may integrate multiple pathways during tissue 
regeneration (Ponomareva et al. 2015). Most differentially expressed genes were 
discovered between Wnt-C59 treated and control embryos after 24 hours post tail 
amputation (hpa) (Ponomareva et al. 2015). I used the same tail regeneration model 
and Porcupine inhibitor Wnt-C59 to more finely investigate the requirement of Wnt 
signaling during axolotl tail regeneration in Chapter 3. 
 
1.5 Fgf signaling pathway and tissue regeneration 
1.5.1 Fgf signaling pathway and Fgfr inhibitor BGJ398 
Fgf signaling is essential for cell proliferation, differentiation, migration, mitogenesis, 
angiogenesis, and embryogenesis (Ornitz and Marie 2015). In vertebrates, there are 22 
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Fgf genes grouped into seven subfamilies and four Fgf receptors (Fgfrs) in vertebrates 
(Dorey and Amaya 2010). Fgf signaling is initiated by the binding of Fgf ligands to 
Fgfrs. A ligand-dependent dimerization event yields a complex consisting of two 
Fgfs, two heparin sulfate chains, and two Fgfrs (Plotnikov et al. 1999). Each Fgf 
ligand binds to two Fgf receptors contacted with each other via the D2 domain and 
trans-phosphorylates each Fgf receptor monomer (Schlessinger 2000). Upon the 
binding of Fgf ligands and its receptors, the tyrosine residues on the docking protein 
Frs2-α is phosphorylated (Hadari et al. 2001). The Ras/Map kinase and PI3/Akt 
pathways act downstream of Fgf signaling (Armstrong et al. 2006). The Ras/Map 
kinase pathway is associated with cellular proliferation and differentiation (Shapiro 
2002). Map kinase effectors include extracellular signal-related kinase (Erk), c-Jun N-
terminal kinase (Jnk), and p38 mitogen-activated kinase (Cargnello and Roux 2011). 
The PI3/Akt pathway is implicated in cell survival and cell fate determination during 
mammal embryonic development (Yu and Cui 2016). BGJ398 is a selective and 
potent Fgfr inhibitor of Fgfr1/2/3 (Guagnano et al. 2011). I used BGJ398 in chapter 4 
to block Fgf signaling during axolotl tail regeneration. I also used BGJ398 in chapter 
5 to assess the requirement of Fgf signaling during axolotl forelimb development.  
 
1.5.2 Fgf signaling pathway during tissue regeneration 
Fgfs have been studied as neurotrophic and mitogenic factors during tissue 
regeneration for more than 40 years (Gospodarowicz 1976). Fgf1 signaling is 
associated with AEC formation and activation of underlying progenitor cells in the 
axolotl limb that have the potential to differentiate into different tissues (Dungan et al. 
2002). Fgf8 is expressed in the basal layer of the AEC, and Fgf8 and Fgf10 are 
upregulated in cells underlying the AEC during axolotl limb regeneration. 
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Denervation prevents Fgf8 and Fgf10 upregulation during axolotl limb regeneration, 
suggesting that Fgf signaling is nerve-dependent (Kolodziej et al. 2001; Han, An, and 
Kim 2001). Indeed, Fgf2 and Fgf8 are expressed in nerve tissue and the AEC during 
axolotl limb regeneration (Mullen et al. 1996). Fgf2 and Fgf8 act as trophic factors to 
maintain Prrx-1 expression in progenitor cells and promote blastema formation during 
axolotl limb regeneration (Mullen et al. 1996; Satoh et al. 2011). Fgf2 and Fgf8, 
together with growth and differentiation factor-5 (Gdf5), are sufficient to substitute 
for nerve induction of limb regeneration (Makanae et al. 2013). Fgf2 and Fgf8 induce 
bump formation during limb regeneration, and Fgf2+Fgf8+Bmp7 or Bmp2 induce 
limb formation during skin wound healing using the accessory axolotl limb model 
(Makanae, Mitogawa, and Satoh 2014).  Fgf2+Fgf8+Bmp7 also induce tail 
regeneration in the axolotl (Makanae, Mitogawa, and Satoh 2016). Ectopic Fgf8 and 
endogenous Hh signaling pathway are sufficient to induce posterior axolotl limb 
regeneration (Nacu et al. 2016).  The requirement for Fgf has also been shown to be 
relatively late for outgrowth of tail tissue in Xenopus by using Fgfr antagonist 
SU5402 and heat shock inducible XFD. The Fgf signaling pathway is also required 
for Xenopus lens regeneration  (Lin and Slack 2008; Fukui and Henry 2011). In the 
zebrafish “devoid of blastema” mutant, a blastema fails to form during fin 
regeneration. It was discovered that this mutant is caused by a Fgf20a null allele, thus 
establishing Fgf signaling is essential for blastema formation during zebrafish fin 
regeneration (Whitehead et al. 2005). Fgf3 and Fgf10a are responsible for the later 
stage of blastemal formation in zebrafish fin regeneration (Shibata et al. 2016). Taken 
together, Fgf signaling is associated with neurotrophic factors that sustain progenitor 
cell proliferation and blastema formation during tissue regeneration.  
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1.6 Interactions of signaling pathways during tissue regeneration 
In response to artificial amputation or natural injury, animals activate a complex 
series of responses which lead to local and systemic changes in molecules that 
function in signaling pathways. Studies have shown that TGF-β, Wnt, and Fgf 
signaling pathways are activated during tissue regeneration in many different species. 
Signaling pathways comprise complex networks that are regulated through positive 
and negative regulatory interactions. Here I provide a brief overview of regulatory 
interactions among the TGF-β, Wnt, and Fgf pathways.  
 
Tgf-β, Wnt, and Fgf signaling pathways interact at multiple levels. First, these 
signaling pathways reciprocally regulate ligand production during development and 
regeneration. For example, Wnt signal pathway inhibitor Wnt-C59 decreases 
transcription of Tgf-β1 and Fgf9 during axolotl tail regeneration (Ponomareva et al. 
2015). Second, nucleus components of different signaling pathways can form 
complexes to regulate shared target genes in a synergistic manner, at least in cell 
culture studies (Edlund et al. 2005). Third, cytoplasmic components of different 
pathways interact to repress or activate specific mechanisms of signal transduction. 
For example, the interaction of Bmp/TGF-b signaling component Smad7, and Wnt 
signaling component Axin stabilizes β-catenin, forming a complex with E-cadherin to 
modulate cell-cell adhesion (Tang et al. 2008). 
 
Because components of signaling pathways interact, it is essential to determine their 
organization in time and space; in other words, it is essential to determine if pathways 
function hierarchically or in parallel, which has proven difficult in tissue regeneration 
studies. For example, inhibiting Wnt/β-Catenin signaling pathway abolishes Fgf8 
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expression in the blastema during Xenopus limb regeneration (Lin and Slack 2008). 
Moreover, Fgf signaling acts downstream of Wnt/β-Catenin in both Xenopus limb 
regeneration and zebrafish fin regeneration (Poss et al. 2000; Yokoyama et al. 2007; 
Stoick-Cooper et al. 2007). However, Fgfr antagonist SU-5402 decreases Wnt3a and 
Wnt5a expression during Xenopus tail regeneration, suggesting that feedback 
regulation of Wnt expression by Fgf signaling is not a simple upstream-downstream 
relationship (Lin and Slack 2008). Although studies have independently established 
the requirement of TGF-β, Wnt, and Fgf signaling pathways in different tissue 
regeneration models, there is a need to examine all three pathways within the context 
of a single model. Such data are fundamental to tackling the more difficult question of 
how signaling pathways interact to regulate tissue regeneration processes.  
 
1.7 Wnt and Fgf signaling pathways during limb development 
Signaling pathway interactions have received greater study in models of limb 
development. During chicken limb development, limb bud outgrowth depends on 
signals from the apical ectodermal ridge (AER) (Hamburger and Hamilton 1992). 
Fibroblast growth factors expressed in the AER are sufficient and necessary for AER 
function in proximal-distal limb outgrowth and patterning (Niswander and Martin 
1993; Saunders 1998; Mariani, Ahn, and Martin 2008). Absence of Fgf4 and Fgf8 
leads to failure of limb development. Wnt signals, including Wnt7a expression in non-
AER limb ectoderm, determines dorsal limb cell identity and thus dorsal-ventral axis 
regulation (Riddle et al. 1995). Therefore, Fgf and Wnt signaling pathways crucially 
determine limb axial polarity (Tickle 2015). A regulatory loop of multiple Wnt 
(Wnt3a, Wnt2b, and Wnt8c) and Fgf (Fgf8 and Fgf10) genes controls limb initiation 
and AER induction (Kawakami et al. 2001). Wnt3a is the earliest known AER marker 
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during limb development, it signals through the canonical β-Catenin pathway and 
mediates the induction of Fgf8 in the limb ectoderm by Fgf10 during AER formation 
(Kengaku et al. 1998; Kawakami et al. 2001). Moreover, gradients of Wnt5a establish 
planar cell polarity in chondrocytes along the P-D axis by regulating Vangl2 
phosphorylation during mice limb development (Gao and Yang 2013; Qian et al. 
2007). 
 
During axolotl limb development, a visible AER does not form. Fgf8 is initially 
expressed in the epidermis in the prospective forelimb region of the limb bud at 
developmental stage 42. Fgf8 is expressed in both epidermis and mesenchyme at one 
day after stage 42, then Fgf8 is expressed mainly in the mesenchyme of the bud until 
digits form approximately 14 days later (Han, An, and Kim 2001). As in other 
vertebrates, sonic hedgehog (Shh) is expressed in posterior regions of the developing 
limb bud (Torok et al. 1999; Nacu et al. 2016). Wnt5a is expressed mainly in the 
distal apical ectoderm at stage 36 of the forelimb and hindlimb bud. Wnt5b is 
observed in the mesenchyme of the forelimb and hindlimb bud at developmental stage 
36 (Ghosh et al. 2008). Wnt7a is expressed diffusely in the distal part of the limb 
throughout limb development (Shimokawa et al. 2013). Most studies of axolotl limb 
development to date have been descriptive and have not used functional approaches to 
test the requirement of key signaling pathways. 
 
1.8 Conclusions and perspective 
Many signaling pathways are activated during tissue regeneration and limb 
development in vertebrates. Studies have shown that TGF-β, Wnt, and Fgf signaling 
pathways are among the most important pathways controlling processes that are 
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necessary for limb development, including limb bud initiation, cell proliferation, and 
patterning. These pathways also play essential roles in regulating processes during 
tissue regeneration, including the formation of the wound epithelium, stimulation and 
migration of progenitor cells, and progenitor cell proliferation. Functional studies are 
needed to test the requirement of TGF-β, Wnt, and Fgf signaling pathways during 
limb development and tail regeneration.  
 
1.9 Rationale 
Recently, a chemical screen was performed to identify molecules that alter molecular 
functions, signaling pathways, and biological processes associated with axolotl tail 
regeneration (Ponomareva et al. 2015). Three specific inhibitors SB505124, Wnt-C59 
and BGJ398 targeting TGF-β, Wnt, and Fgf signaling pathways, respectively, were 
found to block axolotl tail regeneration. In this dissertation, I performed experiments 
to determine how these chemical inhibitors affected processes that are necessary for 
tail regeneration, including mitosis, cell proliferation, and cell orientation during 
axolotl tail regeneration and limb bud outgrowth. 
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CHAPTER 2 TGF-β SIGNALING IS REQUIRED DURING AXOLOTL TAIL 
REGENERATION 
Qingchao Qiu1 
1Department of Neuroscience, University of Kentucky, Lexington, Kentucky 
KEYWORDS: Axolotl, regeneration, tail, Tgf-β, Erk, Akt 
2.1 Abstract 
The Tgf-β signaling pathway	is required for many regenerative processes in 
vertebrates, including salamander limb, frog tadpole tail, and fish fin regeneration. 
Here, I investigated the requirement of Tgf-β signaling pathway	on tail regeneration 
using Mexican axolotl (Ambystoma mexicanum) embryos and chemical inhibitors of 
Smad and non-Smad signaling pathways (SB505124 and Naringenin). Both 
SB505124 and Naringenin completely blocked tail regeneration and reduced levels of 
p-Smad2 and p-Smad3 as early as 1-hour post-amputation. However, more complex 
changes in p-Erk and p-Akt were observed between the chemical treatments. At 1hpa, 
levels of p-Erk and p-Akt were significantly higher in SB505124-treated embryos, but 
significantly lower in Naringenin-treated embryos. At 6hpa and 12hpa, SB505124 
significantly affected levels of p-Erk while Naringenin significantly affected levels of 
p-Akt. Further analyses showed that SB505124 but not Naringenin decreased cell 
proliferation. My results show that Tgf-β signaling	pathway via Smad and non-Smad 
signaling pathways are activated very early after axolotl tail amputation and chemical 
perturbation of these pathways blocks tail regeneration. Overall, my study enriches 
the understanding of signaling network dynamics that underlie tissue regeneration.  
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2.2 Introduction 
Multiple signaling pathways are deployed during regeneration to regulate cellular and 
developmental processes associated with repair and formation of new tissue (Ho and 
Whitman 2008; Singh et al. 2018; Peiris et al. 2016; Herman et al. 2018). Detailing 
where and when signaling pathways are deployed during regeneration is essential to 
understand how regeneration programs are regulated. Cellular and developmental 
processes are often regulated in parallel, and it can be difficult to resolve the onset or 
offset timing of signaling pathway deployment in rapidly developing model 
organisms (Fields and Johnston 2005). To address this issue, we recently developed 
an embryo tail amputation model using the Mexican axolotl (Ponomareva et al. 2015). 
The assay uses hatching stage embryos that are capable of regenerating amputated 
distal tail tips in 7 days. Relative to rapidly growing organisms like Danio rerio 
(zebrafish) and Xenopus laevis (Xenopus), axolotl embryos grow slowly, allowing 
greater temporal resolution of early events during regeneration (Fields and Johnston 
2005; Voss, Epperlein, and Tanaka 2009).  
 
The axolotl embryo model was first used to investigate the Wnt signaling pathway 
during tail regeneration (Ponomareva et al. 2015). Wnt proteins are secreted ligands 
that bind to extra-cellular receptors of the Frizzled family (Willert and Nusse 2012; 
MacDonald and He 2012). In the presence of Wnt ligand, intracellular levels of β-
Catenin increase, and transcriptional target genes are activated (MacDonald, Tamai, 
and He 2009). Using chemical compound Wnt-C59, a potent inhibitor of Wnt ligand 
secretion, Ponomareva et al (2015) inhibited tail regeneration, thus establishing a 
requirement for Wnt signaling. Surprisingly, few differentially expressed genes were 
discovered between Wnt-C59 treated and control embryos before 48 hours post-
23  
 
amputation. Still, the few genes that were discovered at 24hpa and the greater number 
of genes discovered at later time points included many ligands and components of cell 
signaling pathways (e.g. Wnt, Fgf, Bmp, Tgf-β, Egf, Ras/Mapk, Ngf, Notch, Ra, Myc, 
and P53) (Ponomareva et al. 2015). Thus, Wnt signaling yields transcripts that code 
for proteins of multiple signaling pathways, but the timing is delayed relative to early 
wound healing events (< 24hpa) that are likely regulated by other signaling pathways 
(Shah et al. 2012). 
  
A pathway that is likely activated upstream of Wnt during tail regeneration is the Tgf-
β signaling pathway, as it is known to be activated very early in response to injury, 
and it is required for successful zebrafish fin, Xenopus tadpole tail, and axolotl limb 
regeneration (Levesque et al. 2007; Ho and Whitman 2008; Denis et al. 2016; 
Pfefferli and Jazwinska 2017). Tgf-β signaling is generally mediated by Tgf-β, Nodal 
and Activin ligands that bind Tgf-β type II receptors on the cell membrane, causing 
the recruitment and transphosphorylation of Tgf-β type I receptors (Aykul and 
Martinez-Hackert 2016; Zhu et al. 2012; Wrana et al. 1992; Attisano et al. 1993). 
Activated Tgf-β type I receptors phosphorylate Smad2 and Smad3, which then 
complex with Smad4, a co-Smad that mediates translocation into the nucleus to 
regulate transcription (Derynck and Zhang 2003). In addition to canonical 
Smad2/Smad3 signaling, the Tgf-β signaling pathway utilizes non-Smad pathways, 
including Map kinase and phosphatidylinositol-3-kinase/Akt (Zhang 2009; Li et al. 
2013; Li et al. 2016). Recently, inhibitors of Smad3 were used to show that p-Smad2 
but not p-Smad3 mediates Tgf-β signaling during axolotl limb regeneration (Denis et 
al. 2016). Whether this mechanism generally applies to animal models with 
regenerative capacity, as well as other tissues in the axolotl, is unknown.  
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In this study, I used chemical compounds to inhibit components of the Tgf-β signaling 
pathway during axolotl embryo tail regeneration. I show that SB505124 and 
Naringenin both inhibit tail regeneration, and this is associated with alterations in 
canonical Smad2/3 signaling and non-Smad signaling pathways. Interestingly, only 
SB505124 inhibited cell proliferation and thus the mechanism by which Naringenin 
inhibited regeneration remains unknown. 
 
2.3 Materials and Methods 
2.3.1 Regeneration experiments 
Axolotl embryos were reared at 16°C in 40% Holtfreter’s solution. Embryos at 
developmental stage 42 (Bordzilovskaya & Dettlaff, 1989) were used for all the tail 
regeneration experiments (Ponomareva et al. 2015). SB505124 (Selleckchem, Cat. 
#S2186) was dissolved in DMSO to make a 50mM stock solution and used at 10μM 
for regeneration experiments (DaCosta Byfield et al. 2004). DMSO at 0.02% was 
used for controls. Naringenin (Selleckchem, Cat. #S2394) was dissolved in DMSO to 
make a 50mM stock solution and used at 20μM for the regeneration experiments 
(Denis et al. 2016). DMSO at 0.04% was used as controls for Naringenin treatment to 
match the DMSO concentration in the treatment group. Axolotl embryos were 
dechorionated and anesthetized in 0.02% benzocaine, and 2mm of the distal tail tip 
was amputated using a sterile blade. Embryos were reared singly, one per well, in 12-
well microtiter plates for the timing experiments and immunofluorescence (IF) 
staining. Five embryos were reared per well for Western Blot tissue collection. There 
were 9 groups in the titration experiment: 0.02% DMSO control, and 10-4, 10-3, 10-2, 
10-1, 1, 2.5, 5, and 10µM SB505124. There were 7 groups in the timing experiment: 
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0.02% DMSO control and SB505124 administered from 0-12, 12-24, 24-48, 48-72, 
72-120, and 120-144hpa. The embryos were photographed at different post-
amputation time points, and tail length and snout-vent length were measured from the 
images. Statistical analysis was performed using GraphPad Prism software version 6.0 
using Student’s t-test. 
 
2.3.2 Antibodies 
Anti-TGF-β antibody (Cat. #bs-0086R) was obtained from Bioss. Anti-p-Smad2 (Cat. 
#3108), Anti-Smad2 (Cat. #5339S), Anti-Smad3 (Cat. #9523S), Anti-Erk (Cat. 
#4348), Anti-phospho-Erk (Thr202/Tyr204) (Cat. #4370), Anti-Akt (Cat. #9272), 
Anti-phospho-Akt (Ser473) (Cat. #9271), Anti-β-Actin (Cat. #5125S), and Anti-
GAPDH (Cat# 2118) were purchased from Cell Signaling Technology. Anti-p-Smad3 
was a gift from Dr. Stephane Roy (Succursal Centresville Montreal, Quebec Canada). 
Anti-phospho-Histone H3 (Ser10) (Cat. # 05-1336) was purchased from Millipore. 
Goat anti-Rabbit IgG, (H+L) HRP conjugate (Cat. # AP307P) and Goat anti-Mouse 
IgG, (H+L) HRP-conjugated secondary antibodies (Cat. #AP308P) were purchased 
from Millipore. Cy3™ AffiniPure Donkey Anti-Mouse IgG (H+L) (Cat. #715-165-
151) was purchased from Jackson Immune Research. DAPI (4', 6-diamidino-2-
phenylindole, dihydrochloride, Cat. #62247) was purchased from Thermo Scientific. 
 
2.3.3 Immunochemistry staining 
A previous protocol was modified for immunochemistry staining (Qiu et al. 2015). In 
brief, samples were fixed in 4% Paraformaldehyde (PFA) overnight. Samples were 
dehydrated through a methanol series, starting in 100% PBS and then 25, 50, 75, and 
100% methanol. These samples were saved at -20ºC for later use. Samples were 
26  
 
rehydrated for whole-mount staining or OCT embedding. After OCT embedding, 
8μM sections were prepared for staining or saved at -80°C for later use. Primary Anti-
TGF-β 1antibodies were used at 1: 200. Primary Anti-phospho-Histone H3 (Ser10) 
antibodies were used at 1:1000. The secondary Cy3™ AffiniPure Donkey Anti-
Mouse IgG (H+L) antibodies were used at 1:200. Blocking solution was 5% sheep 
serum. Total DNA was labeled by DAPI. Stained slides were imaged using a confocal 
microscope (Nikon Tie and C2+ Confocal). A mitotic index was determined by 
dividing the number of histone H3 positive cells by the number of DAPI positive cells 
within 200μm of the tail tip. Statistical analysis was performed using GraphPad Prism 
software version 6.0 using Student’s t-test. 
 
2.3.4 Western blotting 
Embryos that had been administered tail amputations were anesthetized with 0.02% 
benzocaine and 1mm of the distal tail tip was cut using a sterile blade. Tail tips of 30 
embryos were pooled for each sample. The pooled tail tips were washed two times 
using 1x PBS solution with proteinase/phosphatase inhibitor mixture (#5872S, Cell 
Signaling Technology), and then lysed in RIPA buffer (#R0278, Sigma) with 
proteinase/phosphatase inhibitor mixture by using a 22.5-gauge needle and 1 ml 
syringe. The protein concentrations were determined by a BCA protein assay 
(#23225, Thermo Scientific). Equal amounts of tissue lysate were loaded into lanes of 
10% SDS polyacrylamide gels and transferred to PVDF membranes. The membranes 
were blotted with 5% non-fat milk and then incubated overnight at 4°C with primary 
antibodies and were followed by HRP-conjugated secondary antibodies. The immune 
complexes were detected by enhanced chemiluminescence (Cat# NEL103001, 
PerkinElmer). Quantification of band intensities was performed using the ImageJ 
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software (http://rsbweb.nih.gov/ij/). The data were shown as mean ± SD. Statistical 
analyses were performed by GraphPad Prism software version 6.0. using Student’s t-
test. 
 
2.3.5 EdU cell proliferation assay 
An EdU cell proliferation assay was performed using FAM picolyl azide from Click 
Chemistry Tools (Cat. # 1180-1), along with CuSO4 and sodium ascorbate in the 
Click-iTTM EdU Alexa FluorTM 488 Imaging Kit from Invitrogen (Cat. # C-10337).  
The protocol was modified for whole-mount staining and cryo-section staining. 
Briefly, axolotl embryos were tail amputated and placed in 12-well-plates with 0.02% 
DMSO, 0.04% DMSO, 10μM SB505124, or 20µM Naringenin solution. At 48hpa, 
embryos were injected intraperitoneally with 1ul of 8μM 5-ethynyl-2’-deoxyuridine 
(EdU). At 72hpa, embryos were anesthetized with 0.02% benzocaine and fixed in 4% 
paraformaldehyde overnight. The samples were dehydrated and rehydrated using a 
methanol series (0, 25, 50, 75, and 100% in PBS). The samples were washed with 
PBS with 1% Triton for 3x5 minutes, then bathed in 2.5% trypsin for 30 minutes and 
washed with icy cold acetone for 10 minutes following PBS with 1% Triton 3x5 
minutes. Click-iT EdU reaction solution containing 1x Tris-buffered saline, 4mM 
CuSO4, FAM 488 picolyl azide, and 100mM sodium ascorbate was used to visualize 
EdU incorporation into the DNA of proliferating cells. DAPI was used to counter 
stain DNA within cells. Cells staining positive for EdU within 400µm of the tail tip 
were counted as well as cells staining positive for DAPI within the same area. A 
proliferative index was calculated as a ratio of EdU positive cells over DAPI positive 
cells. For cryo-section staining, trypsinization and ice-cold acetone washing steps 
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were skipped. Results were analyzed in GraphPad Prism software version 6.0 (San 
Diego California USA) using Student’s t-test.  
 
2.4 Results 
2.4.1 Tgf-β signaling is required during axolotl tail regeneration. 
A Tgf-β receptor Alk5/4/7 inhibitor, SB505124, was previously shown to inhibit 
axolotl tail regeneration using a 10µM dose (Ponomareva et al. 2015; DaCosta 
Byfield et al. 2004). To verify this result and more comprehensively examine dosage, 
I treated embryos with different concentrations of SB505124 (0, 10-4, 10-3, 10-2, 10-1, 
1, 2.5, 5, and 10µM) (Figure2.1 A). The treated embryos appeared healthy and active 
for all treatments tested. Doses of SB505124 above 0.01µM inhibited tail regeneration 
at 7dpa (Figure2.1 B). By varying the time that SB505124 was administered, I 
detected significant differences in tail length at 7dpa when treating embryos from 0-
12hpa, 12-24hpa, and 48-72hpa (Figure2.1 C). In contrast, I did not detect significant 
differences in snout-vent length at 7dpa (Figure2.1 D). These results show that 
SB505124 efficiently blocks tail regeneration without affecting overall embryo 
growth and development. These results suggest that Tgf-β signaling is required for 
axolotl tail regeneration. 
  
To further investigate the requirement of Tgf-β signaling, I treated embryos with 
Naringenin, a small molecule that inhibits phosphorylation of Smad3, an intracellular 
protein that mediates Tgf-β signal transduction (Ortiz-Andrade et al. 2008; Denis et 
al. 2016). I tested 8 embryos for 4 different concentrations of Naringenin (0, 10, 20, 
and 35µM) (Figure2.2 A-C). The 35µM treatment was toxic, all embryos died. 
Relative to controls, embryos treated with 10µM showed a marginal decrease in tail 
29  
 
length at 7dpa, indicating partial inhibition of regeneration. In contrast, 20µM 
Naringenin significantly inhibited tail regeneration at 7dpa (Figure2.2 D). Although 
the 20µM treated embryos appeared healthy and normal, I noted that the outer 
margins of their tailfins presented an abnormal white coloration. This white tissue 
may reflect necrosis of epithelial cells during prolonged treatment of Naringenin at 
20µM. However, Naringenin completely inhibited regeneration at this concentration, 
consistent with an early disruption of the Tgf-β signaling pathway. 
               
Figure 2.1 Inhibiting Alk4/5/7 by SB505124 blocks axolotl tail regeneration.  
A and B) SB505124 treatments above 0.01µM significantly inhibited axolotl embryo 
tail regeneration. C) 10µM of SB505124 was administered at different time periods 
and tail length was measured. Tail length at 7dpa differed significantly between 
DMSO treated controls (1.53 ± 0.26mm) and SB505124 treatments of 0-12 (0.54 ± 
0.29mm), 12-24 (1.01 ± 0.03mm), and 48-72hpa (0.90 ± 0.22mm). D) No significant 
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difference in snout-vent length was detected between SB505124 treated and DMSO 
treated controls. *: p value < 0.05 for contrasts of DMSO control vs SB505124.  
                        
 
Figure 2.2 Naringenin inhibits axolotl tail regeneration.  
A-D) Naringenin inhibited axolotl tail regeneration at 7dpa. D) Tail growth was 
significantly less for 20µM Naringenin treated embryos (0.92 ± 0.22mm) relative to 
DMSO controls (2.45 ± 0.38mm). *: p value < 0.001 for contrasts of DMSO control 
vs Naringenin. 
 
 2.4.2 Tgf-β1 increases during tail regeneration. 
Previous studies have established that the Tgf-β signaling pathway is required for 
axolotl limb regeneration (Levesque et al. 2007; Jhamb et al. 2011; Denis et al. 2016). 
In particular, Levesque et al. (2007) showed that Tgf-β1 mRNA is upregulated very 
early (6hpa) following limb amputation and strongly expressed in the blastema at the 
early bud stage. To determine if Tgf-β1 is also expressed during axolotl embryo tail 
regeneration, I stained for Tgf-β1 at 0, 3, and 6hpa. Tgf-β1 was broadly expressed in 
the tail at the time of amputation, particularly in the epidermis and myotomes 
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(Figure2.3 A).  Tgf-β1 expression significantly decreased at 3hpa (Figure2.3 A-D, n = 
6, p < 0.05) but was significantly higher than basal levels at 6hpa, prominently in cells 
of the wound epidermis (Figure2.3 A-D, n = 6, p < 0.05). These data show that Tgf-β1 
is dynamically regulated in response to tail amputation.  
             
Figure 2.3 Tgf-β1 is broadly expressed in the axolotl tail and increases in the 
epidermis during tail regeneration.  
A) Tgf-β1 expression at 0hpa in the tail tip. Relative to Tgf-β1 expression in the 
epidermis at 0hpa, expression was significantly lower at 3hpa (B) but significantly 
higher at 6hpa (C). * p < 0.001 for contrasts of DMSO control vs SB505124. MM: 
Mesenchymal tissue; SC: Spinal cord; NC: Notochord; MC: Muscle cells; ED: 
Epidermis tissue. SCA: Spinal cord ampulla. 
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2.4.3 Smad-mediated Tgf-β signaling increases during axolotl tail regeneration. 
Tgf-β signaling during axolotl limb regeneration is associated with phosphorylation of 
Smad2 and Smad3 (Denis et al 2016). To determine if Smad2/3-mediated Tgf-β 
signaling during axolotl tail regeneration, I quantified phosphorylated Smad2 (p-
Smad2) and Smad3 (p-Smad3) expression using pooled 2 mm tail tips by Western 
Blotting. Levels of Smad2 and Smad3 were constant for all samples analyzed, while 
p-Smad2 and p-Smad3 levels were more variable (Figure2.4A). P-Smad2 increased 
from 1hpa to 12hpa (Figure2.6 A and B) while the expression of p-Smad3 was 
relatively constant (Figure2.4A and C). Embryos were next treated with SB505124 to 
determine if p-Smad2 and p-Smad3 were specifically mediated by Tgf-β signaling, in 
comparison to control embryos; SB505124 significantly decreased p-Smad2 at 1, 6, 
and 12hpa (45.1%, 71.1%, and 74.5%, respectively) (Figure2.4 A and B). P-Smad3 
was not significantly inhibited by SB505124 at 1 h, but p-Smad3 levels were 
significantly lower at 6 and 12hpa (57.9% and 36.9%, respectively) (Figure2.4A-C). 
The results show that SB505124 treatment affected p-Smad2 earlier and to a greater 
degree than p-Smad3, but inhibition of Tgf-β signaling decreased phosphorylation of 
both proteins.  
 
I next performed Western blotting to determine if Naringenin inhibited tail 
regeneration via its predicted blockade of Smad3 phosphorylation (Denis et al. 2016). 
In control embryos, p-Smad2 levels increased slightly at 1hpa, but greatly at 6 and 
12hpa. At each of these time points, Naringenin treated embryos showed significantly 
reduced levels of p-Smad2 (Figure2.5 A and B). The p-Smad3 expression profiles for 
control and treated embryos also showed differences in both timing and magnitude of 
expression. In control embryos, p-Smad3 increased precipitously at 1hpa, but after 
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this time levels decreased. Levels of p-Smad3 also increased in Naringenin treated 
embryos. However, peak expression was observed at 6hpa. As a result, p-Smad3 
levels were significantly lower in Naringenin treated embryos at 1hpa, but 
significantly higher than those of controls at 6hpa (Figure2.5 A and C). Thus, 
Naringenin decreases and delays p-Smad3 expression after tail amputation. Overall, 
these expression patterns show that Naringenin alters phosphorylation dynamics of 
Smad2 and Smad3 proteins that mediate Tgf-β signaling.  
                    
Figure 2.4 SB505124 significantly affects p-Smad2 and p-Smad3 expression.  
A) Smad2, p-Smad2, Smad3, and p-Smad3 were detected by Western blotting using 
pooled 1mm tail tips from SB505124 treated or DMSO control embryos at 0, 1, 6, and 
12hpa. B) P-Smad2 expression was normalized against total Smad2.  C) P-Smad3 
expression was normalized against total Smad3. *: p-value < 0.05 for contrasts of 
DMSO control vs SB505124.  
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Figure 2.5 Naringenin significantly affects activation of Smad2 and Smad3. A) 
Western blotting of Smad3, p-Smad3, Smad2, and p-Smad2 using pooled 1mm tail 
tips from 20µM Naringenin (NA) treated or DMSO treated embryos tail tips collected 
at 0, 1, 6, and 12hpa. B) P-Smad2 expression was normalized against total Smad2. C) 
P-Smad3 expression was normalized against total Smad3.  *: p-value < 0.05 for 
contrasts of DMSO control vs Naringenin. 
 
2.4.4 Non-Smad mediated Tgf-β signaling pathways are up-regulated by SB505124 
and down-regulated by Naringenin at 1hpa. 
Previous studies have shown that Tgf-β ligands mediate intracellular signaling via 
non-Smad mediated pathways (Ho and Whitman 2008; Bassat et al. 2017; Bakin et al. 
2000). To investigate non-Smad mediated Tgf-β signaling pathways, phosphorylated 
Erk (p-Erk) and Akt (p-Akt) signaling were quantified by Western blotting. Both p-
Erk and p-Akt were detected at the time of tail amputation. However, these proteins 
presented different post-amputation expression profiles between control and 
SB505124-treated tails. While p-Erk was increased in both control and SB505124-
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treated embryos at 1hpa, expression was significantly higher in the later (Figure2.6 A 
and B). Phosphorylated Akt did not significantly change at 1hpa but decreased at 6 
and 12hpa in control embryos. SB505124 treatment increased Akt phosphorylation at 
1hpa and had no significant effect at 6 and 12hpa (Figure2.6 A and C). P-Erk was 
significantly down-regulated in Naringenin-treated embryos at 1hpa compared with 
controls (Figure2.7 A and B). Naringenin also significantly down-regulated p-Akt 
following tail amputation at all time points (Figure2.7 A and C). These results show 
that Erk and Akt activation are up-regulated by SB505124 and down-regulated by 
Naringenin during early tail regeneration.  
 
                           
Figure 2.6 SB505124 increases phosphorylation of non-Smad mediated signaling Erk 
and Akt at 1hpa. A) Erk, p-Erk, Akt, p-Akt, and β-actin were detected by Western 
blotting using pooled 1mm tail tips from SB505124 treated or DMSO control 
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embryos at 0, 1, 6, and 12hpa. B) P-Erk expression was normalized against Erk. C) P-
Akt expression was normalized against Akt. *: p-value <0.05 for contrasts of DMSO 
control vs SB505124. 
 
                       
Figure 2.7 Naringenin down-regulates p-Erk and p-Akt signaling at 1hpa. A) Western 
blotting of total Erk, p-Erk, Akt, p-Akt, and β-actin using pooled 1mm tail tips from 
Naringenin treated or DMSO control tails. B) P-Erk expression was normalized 
against Erk. C) P-Akt expression was normalized against Akt. *: p value < 0.05 for 
contrasts of DMSO control vs Naringenin. 
 
2.4.5 SB505124, but not Naringenin, significantly reduces cell proliferation. 
Tgf-β signaling pathway is required for cell proliferation during tail regeneration in 
Xenopus laevis tadpoles (Ho and Whitman 2008). To determine whether Tgf-β 
signaling regulates cell proliferation during axolotl tail regeneration, EdU 
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incorporation was used to detect proliferating cells from 48 to 72hpa. In DMSO 
control tails, proliferating cells were observed in the regenerating bud, especially 
within 400µm of the tail tip (Figure2.8 A-A’’), while SB505124 treatment reduced 
cell proliferation within multiple regions of the tail including dorsal fins, ventral fins, 
and spinal cord (Figure2.8 B-B’’ and D, n = 6, p < 0.001). In contrast, Naringenin 
treatment did not reduce cell proliferation significantly in these tissues (Figure2.8 C-
C’’ and E, n = 4, p > 0.05). These data show that SB505124 downregulates cell 
proliferation during tail regeneration, while Naringenin does not.  
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Figure 2.8 SB505124, but not Naringenin, significantly reduces cell proliferation at 
72hpa.  Images A”, B”, and C” are cryo-sections of regenerating tails. All the other 
images are the whole-mount and regenerating tails. A) DMSO control stained for 
EdU. A’) DMSO control stained with DAPI. A’’) DMSO control stained for EdU and 
DAPI. B) Tail treated with SB505124 and stained for EdU. B’) Tail treated with 
SB505124 and stained with DAPI. B’’) Tail treated with SB505124 and stained for 
39  
 
EdU and DAPI. C) Tail treated with Naringenin and stained for EdU. C’) Tail treated 
with Naringenin and stained with DAPI. C’’) Tail treated with Naringenin and stained 
with EdU and DAPI. D) Proliferative index for the tail tip and spinal cord. For dorsal 
or ventral fins, cells were counted in whole-mount staining samples. E) Proliferative 
index for Naringenin treated and control samples. *: p-value < 0.001 for contrasts of 
DMSO control vs SB505124. 
 
2.4.6 Tgf-β signaling regulates cell mitosis during tail regeneration. 
To determine whether the cell proliferation response during tail regeneration 
associates with cell mitosis, a mitotic marker, anti-phospho-histone H3 (Ser10), was 
used to detect mitotic cells. In DMSO treated controls, the mitotic index was 7.6 ± 
2.8%. SB505124 treatment significantly reduced the mitotic index to 2.4 ± 1.0% 
(Figure2.9 A-C, n = 3, p < 0.05). These results strongly suggest that Tgf-β signaling 
regulates cell mitosis during tail regeneration. 
      
Figure 2.9 SB505124 inhibits the mitotic index within tail tips at 48hpa.  A) DMSO 
control tail stained with phospho-histone H3 in red. The total nuclear DNA was 
labeled with DAPI. The white stippled lines outline the tail.  B) SB505124 treated tail 
stained with phospho-histone H3. C) Graph comparing the mitotic index in DMSO 
control and SB505124 treated tails. *: p-value < 0.05 for contrasts of DMSO control 
vs SB505124. 
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2.5 Discussion 
Ligands of the Tgf-β super family associate with axolotl tail regeneration. 
Tgf-β ligands are pleiotropic cytokines whose activities depend on their receptor-
binding partner and intracellular signaling components. In mammals, there are 
approximately 33 ligands in the Tgf-β family (Aykul and Martinez-Hackert 2016). In 
this chapter, Tgf-β1 was shown to be up-regulated during axolotl tail regeneration. 
This result is consistent with studies of other tissue regeneration models. For example, 
Tgf-β1 is upregulated during axolotl limb and tadpole tail regeneration (Denis et al. 
2016; Levesque et al. 2007). However, SB505124 inhibits multiple type I receptors 
(Alk5/4/7). Ligands, in addition to Tgf-β1, which are thought to signal through Alk5, 
may orchestrate Tgf-β signaling during axolotl tail regeneration. For example, Tgf-β2 
and Tgf-β5 are up-regulated during Xenopus tail regeneration, and they are thought to 
function in wound epithelium formation and establishment of the regeneration bud, a 
structure that forms very early in tadpole regeneration (Ho and Whitman 2008). Also, 
these Tgf-β ligands are thought to regulate cell proliferation through their effects on 
Erk signaling (Ho and Whitman 2008). In lizard tail regeneration, Tgf-β1 expression 
is limited while activin-βA is strongly upregulated. Morpholino knockdown of 
activin-βA or its receptor Alk4 impairs zebrafish fin regeneration (Jazwinska, 
Badakov, and Keating 2007). Inhibin could be another important ligand during tail 
regeneration based on results of a previous axolotl tail microarray study which 
showed significant upregulation of inhbb at 48hpa (Ponomareva et al. 2015). Inhbb 
shares a β subunit with activin and its function is thought to oppose activin (Zhu et al. 
2012; Namwanje and Brown 2016). In future studies, it will be important to 
investigate activin and inhibin during axolotl tail regeneration. Overall, my results and 
other studies clearly implicate Tgf-β ligands in early tissue regeneration responses. 
41  
 
 
Dynamic regulation of p-Smad2 and p-Smad3 by Tgf-β signaling during tail 
regeneration 
In this study, I showed that chemical disruption of Tgf-β signaling altered Smad2 and 
Smad3 phosphorylation. In control embryos, p-Smad2 and p-Smad3 dynamically 
increased following tail amputation. Both Smad2 and Smad3 were activated upon tail 
amputation as early as 1hpa and p-Smad2 steadily increased after this time while p-
Smad3 decreased. Application of SB505124 down-regulated both p-Smad2 and p-
Smad3 at all post-amputation time points and blocked tail regeneration. Naringenin 
also down-regulated p-Smad2 at all post-amputation time points and delayed peak p-
Smad3 expression and completely blocked tail regeneration. However, SB505124 
treatment affected p-Smad2 at an earlier time and to a greater degree than p-Smad3, 
while Naringenin affected p-Smad3 at an earlier time and to a greater degree than p-
Smad2. Activation of p-Smad2 has been reported at 1hpa during Xenopus tail 
regeneration and 6hpa during axolotl limb regeneration; these results are consistent 
with my findings (Ho and Whitman 2008; Denis et al. 2016). Denis et, al (2016) 
reported that only phosphorylation of Smad2, but not phosphorylation of Smad3, is 
required for axolotl limb regeneration (Denis et al. 2016). This contrasts with my 
findings, as I found that pSmad3 inhibitor Naringenin blocked tail regeneration. 
Additional studies are needed to understand the differential requirements for Smad2 
and Smad3 signaling during axolotl limb and tail regeneration.  
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Dynamic regulation of p-Erk and p-Akt by the Tgf-β signaling pathway during 
tail regeneration 
Erk and Akt are two non-Smad mediated Tgf-β signaling pathways (Zhang 2009). Erk 
signaling is a central cassette of the mitogen-activated protein kinase (Mapk) 
signaling pathway that regulates mammalian wound contraction and cell proliferation 
(Shaul and Seger 2007; Li et al. 2013; Li et al. 2016). Tgf-β signaling also activates 
Akt signaling; inhibition of Tgf-β type I receptor prevented the activation of Akt that 
functions in mammalian cell survival (Bakin et al. 2000). In this study, I found that p-
Erk and p-Akt responded to tail amputation at an early phase of tail regeneration. In 
DMSO control embryos, the expression pattern of p-Erk and p-Akt in SB505124 and 
Naringenin were different. One possible reason is that embryos used for these 
different experiments came from different genetic backgrounds that may exhibit 
variability in cell signaling. Another possible reason is that the DMSO concentration 
in the Naringenin experiments was 0.04%, which is 1x higher than the DMSO 
concentration in the SB505124 experiment. Studies have shown that DMSO 
concentration may differentially alter cell membrane structure, ubiquitination sites, 
and affect oxidative phosphorylation (ATP synthesis) leading to variation in signal 
transduction, protein degradation, and protein phosphorylation (Majdi et al. 2017; 
Doellinger et al. 2018; Syed, Skonberg, and Hansen 2013; Julien et al. 2012). 
However, the effects of DMSO on axolotl cells is unknown. In regard to protein 
phosphorylation, I used a high concentration of proteinase/phosphatase inhibitor 
during sample collection. Despite differences in the expression levels of p-Erk and p-
Akt in the DMSO controls, their patterns were somewhat similar for the first 6hpa. In 
both of the DMSO control samples, p-Erk was expressed at the time of tail 
amputation, increased at 1hpa and then decreased at 6hpa, although the decrease was 
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much greater in the Naringenin experiment. P-Akt was expressed at the time of tail 
amputation. It changed very little at 1hpa and decreased at 6hpa. These data suggest 
that both Erk and Akt were dynamically changed following tail regeneration. Overall, 
increased expression of p-Erk and decreased expression of p-Akt appear to be 
important early signaling responses. Furthermore, p-Erk and p-Akt were significantly 
up-regulated in SB505124-treated tails, but significantly down-regulated in 
Naringenin-treated tails at 1hpa, showing that p-Erk and p-Akt are affected by 
disruptions of Tgf-β signaling. Temporal changes in p-Erk and p-Akt have been 
observed in other studies. For example, Erk phosphorylation is upregulated in the 
wound epithelium at 8hpa and in mesenchymal cells under the wound epithelium at 
48hpa during Xenopus tail regeneration (Ho and Whitman 2008). These two periods 
of Erk phosphorylation are consistent with my results which showed inhibition of tail 
regeneration at these times. The first 0-24 hours is an important injury response phase 
wherein genes are expressed to facilitate wound healing. Transcription between 48-
72hpa time course may regulate cell proliferation. Also, in the Xenopus limb 
regeneration model, Erk phosphorylation is upregulated in the wound epithelium at 
48hpa and mesenchymal cells under the wound epithelium at 96hpa while Akt 
phosphorylation is up-regulated in the mesenchymal cells from 24hpa to 96hpa 
(Suzuki et al. 2007). Overall, these studies suggest an important role for pathways that 
mediate non-Smad Tgf-β signaling during early amphibian appendage regeneration. 
 
Tgf-β signaling regulates mitogenic activity and cell proliferation response 
during axolotl tail regeneration. 
In cell culture models, it is widely accepted that Tgf-β signaling inhibits the growth of 
certain non-transformed epithelial, endothelial, and primary fibroblasts of embryonic 
44  
 
origin (Moses 1992; Ten Dijke et al. 2002). However, Tgf-β signaling facilitates 
mitogenic activity in some transformed cells and immortalized fibroblasts 
(Alexandrow and Moses 1995). In cancer biology, it is known that the action of Tgf-β 
signaling depends on cell type and growth conditions; it acts as a tumor suppressor at 
early stages and stimulates tumor proliferation at later stages (Fabregat et al. 2014). In 
tissue regeneration models, Tgf-β pathway regulation of cell proliferation is also 
tissue-dependent. In zebrafish, Tgf-β signaling promotes cell proliferation during fin 
and heart regeneration, but negatively regulates cell proliferation in retinal 
regeneration (Tappeiner et al. 2016). In axolotl tail regeneration, I detected 
significantly higher cell proliferation and mitosis in control embryos than in 
SB505124 treated embryos at 72hpa and 48hpa, respectively. Therefore, my data 
indicate that Tgf-β signaling plays an important role in regulating cell proliferation 
responses during tail regeneration. 
  
Naringenin targets multiple signaling pathways in addition to p-Smad3 
phosphorylation. 
Naringenin inhibited p-Smad2, p-Smad3, p-Erk, and p-Akt as early as 1hpa, and 
blocked tail regeneration. The inhibitory effect of Naringenin on axolotl tail 
regeneration contrasts with the result of Denis et al (2016), who did not find that 
Naringenin inhibited axolotl limb regeneration. They concluded that p-Smad3 is not 
required during axolotl limb regeneration while my result suggests that p-Smad3 is 
required for axolotl tail regeneration. It is possible that Naringenin may have a 
broader inhibitory effect in the axolotl embryo model than the adult limb model, as 
multiple signaling pathways are operative during early development. In other words, 
Naringenin targets multiple signaling pathways in addition to p-Smad3. Consistent 
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with this interpretation, my study is the first to show that Naringenin downregulates p-
Smad2, p-Erk, and p-Akt during tissue regeneration. 
 
A cell proliferation response at 72hpa is necessary, but not sufficient for tail 
regeneration. 
SB505124 treatment decreased cell proliferation at 72hpa and prevented tail 
regeneration. These results suggest that Tgf-β signaling regulates a cell proliferation 
response that is necessary for successful tail regeneration. However, other processes 
than cell proliferation are necessary for tail regeneration because Naringenin did not 
inhibit cell proliferation at 72hpa but did block tail regeneration. It will be important 
in future studies to perform dose and timing experiments for Naringenin to identify 
the key periods for Naringenin inhibition of tail regeneration and more thoroughly 
investigate how this drug affects cell mitosis. 
 
In this chapter, I found: 1) Tgf-β1 is upregulated during tail regeneration. 2) Both 
Smad mediated Tgf-β signaling and non-Smad mediated Tgf-β signaling are activated 
as early as 1hpa during axolotl tail regeneration. 3) Blocking Tgf-β signaling by 
SB505124 or Naringenin prevents axolotl tail regeneration. 4) Tgf-β signaling 
regulates cell proliferation and cell mitosis during axolotl tail regeneration. Overall, 
my study enriches understanding of Tgf-β signaling pathway dynamics underlies 
tissue regeneration. 
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CHAPTER 3 WNT SIGNALING IS REQUIRED DURING AXOLOTL TAIL 
REGENERATION 
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3.1 Abstract 
Wnt signaling pathway is activated during tissue regeneration. Palmitoylation of Wnts 
by Porcupine is critical for Wnt protein secretion and activity. Here I investigated the 
requirement of Wnt signaling on tail regeneration using Mexican axolotl (Ambystoma 
mexicanum) embryos and Porcupine inhibitor Wnt-C59. Continuous Wnt-C59 
treatment completely blocked tail regeneration at 7 days post tail amputation (dpa). 
Temporal dosing experiments showed that Wnt signaling is required from 0-120 
hours post-amputation (hpa). Individuals that were removed from Wnt-C59 treatment 
at 7dpa regenerated somatic tissues of the body axis, but not dorsal and ventral fins. 
Strikingly, Wnt-C59 released individuals did not develop their forelimbs, and 
hindlimb development was abnormal. Levels of Wnt3a were significantly lower than 
pre-amputation levels at 24 and 72hpa. β-Catenin levels decreased in DMSO-treated 
embryos after tail amputation and were significantly lower than pre-amputation levels 
at 48hp, but significantly higher at 72hpa. Inhibiting Wnt signaling by Wnt-C59 
increased the β-Catenin level and upregulated Erk and Akt phosphorylation. 
Additionally, inhibition of Wnt signaling reduced cell mitosis at 24 hpa and cell 
proliferation at 72hpa. These data suggest that Wnt signaling regulates β-Catenin, 
Erk, and Akt signaling and controls cell mitosis and cell proliferation during axolotl 
tail regeneration. My results show that Wnt signaling is required for axolotl tail 
regeneration. 
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3.2 Introduction 
Salamanders regenerate many body parts including limbs, tail, lens, heart, spinal cord, 
and brain (Sugiura et al. 2016; Nacu et al. 2016; Franklin, Voss, and Osborn 2017; 
Suetsugu-Maki et al. 2012; Nakamura et al. 2016; Tazaki, Tanaka, and Fei 2017; 
Amamoto et al. 2016). Salamander appendages harbor lineage-restricted progenitor 
cells and multipotent cells that are recruited after injury to reform missing or damaged 
tissues (Tanaka and Reddien 2011). For example, cell lineage tracing during Xenopus 
tail regeneration showed that the spinal cord regenerates from progenitors within the 
spinal cord, while new muscle is reformed by satellite cells within muscle tissue 
(Gargioli and Slack 2004). Despite those advances in understanding tissue 
regeneration at the cellular level, how injury activates signaling pathways to guide 
progenitor cell behaviors is still poorly understood. For example, while it has been 
established that Wnt signaling is required for axolotl embryo tail regeneration 
(Ponomareva et al. 2015), the temporal requirements and effects of Wnt signaling on 
cellular and developmental processes have not been characterized in this model.  
 
Wnt proteins have been found to play a myriad of biological roles in controlling tissue 
regeneration among many species (Zhao et al. 2019; Fan et al. 2018; Wischin et al. 
2017; Ghosh et al. 2008; Kawakami et al. 2006). Wnt protein binds N-terminal 
extracellular cysteine-rich domain of a 7 transmembrane molecule Frizzled (Fz) 
family receptor, which interacts with co-receptors including lipoprotein receptor-
related (LRP) 5/6, ROR2, and receptor tyrosine kinase (RTK) (Komiya and Habas 
2008). Upon activation, Fz directly binds to Dsh, which has three conserved protein 
domains: a central PDZ domain, an amino-terminal DIX domain, and a carboxy-
terminal DEP domain (Wong et al. 2003). There are three Wnt signaling pathways: 
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the canonical Wnt/β-Catenin pathway and two pathways that function independent of 
β-Catenin, the Wnt/planar cell polarity (PCP) pathway and Wnt/calcium pathway 
(Habas and Dawid 2005).  
 
Canonical and non-canonical Wnt signaling pathways are required during tissue 
regeneration to control different aspects of tissue regeneration (Kawakami et al. 2006; 
Ghosh et al. 2008; Shimokawa et al. 2013; Hamilton, Sun, and Henry 2016; 
Yokoyama et al. 2011; Sugiura et al. 2009; Lin and Slack 2008). Upon depletion of β-
Catenin, an amputated planarian tail regenerates into a head. This suggests that β-
Catenin maintains anteroposterior identity during homeostasis and regeneration in 
planarians (Petersen and Reddien 2008; Gurley, Rink, and Sanchez Alvarado 2008). 
Using a genetic construct to inhibit Wnt/β-Catenin signaling, Kawakami et al (2006) 
prevented limb regeneration in axolotl larvae and fin regeneration in zebrafish. 
Moreover, they showed that the surprising ability of early-stage chick embryos to 
regenerate limbs is associated with β-Catenin signaling (Kawakami et al. 2006). Non-
canonical Wnt signaling pathways are also crucial to regulate tissue regeneration. 
Two non-canonical Wnt genes, Wnt5a and Wnt5b, are expressed during axolotl limb 
regeneration (Ghosh et al. 2008). Overexpression of Wn5a induces the development 
of ectopic tails in Xenopus tadpoles at the site of a dorsal incision; presumably, this is 
mediated by Wnt/Jnk signaling (Sugiura et al. 2009). Thus, both canonical and non-
canonical Wnt signaling pathways are required in multiple types of tissue 
regeneration across species. 
 
However, in some cases, the use of tools to inhibit Wnt signaling has not yielded 
inhibitory regeneration outcomes. For example, a heat-shock inducible genetic 
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construct encoding the Wnt antagonist Dkk1 did not prevent Xenopus limb or lens 
regeneration (Yokoyama et al. 2011; Hamilton, Sun, and Henry 2016). Yokoyama et 
al (2011) hypothesized that nerve-derived signals could compensate for Wnt signaling 
during the initiation of Xenopus limb regeneration. Other studies have shown that 
Wnt-pathway agonists can inhibit regeneration, including axolotl limb and Xenopus 
lens regeneration (Wischin et al. 2017; Hamilton, Sun, and Henry 2016). In the 
axolotl study, Wnt agonist treatment before blastema formation inhibits limb 
regeneration, possibly by affecting innervation, while treatment after blastema 
formation causes disorganized skeletal elements to form (Wischin et al. 2017). A 
similar phenomenon has been shown during limb development; stabilization of β-
Catenin during early stages of limb development leads to early regression of the 
apical epidermal ridge and results in truncated limbs (Hill et al. 2006), while it causes 
skeletal abnormalities during later stages (Akiyama et al. 2004). During axolotl tail 
regeneration, both Wnt agonist SKL, which increases Wnt/β-Catenin signaling, and 
Wnt antagonist IWR-1-endo which decreases Wnt/β-Catenin signaling, inhibits tail 
regeneration (Ponomareva et al. 2015). This suggests that successful tissue 
regeneration requires proper spatial-temporal regulation of Wnt/β-Catenin signaling, 
especially the timing of β-Catenin activation (Kawakami et al. 2006).  
 
Ponomareva et al. (2015) found that inhibiting Wnt signaling pathway by Wnt-C59 
blocks axolotl tail regeneration. Moreover, Wnt-C59 treatment affects transcription of 
genes associated with Wnt, Fgf, Tgf-β, Hox, Egf, Myc, Notch, Ngf, Ras/Mapk, p53, 
and retinoic acid (RA) pathways. Most differentially expressed genes were discovered 
between Wnt-C59 treated and control embryos after 24 hours post tail amputation 
(hpa). These data demonstrated that Wnt signaling interacts with other signaling 
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pathways to regulate tail regeneration. However, the temporal requirement of Wnt/β-
Catenin signaling pathway during axolotl tail regeneration is unknown. In this study, I 
used the chemical compound Wnt-C59 to inhibit Wnt protein secretion and activity 
during axolotl embryo tail regeneration. I demonstrate that Wnt signaling is required 
from 0 to 120 hours post tail amputation. The Wnt-C59 treatment completely 
prevented tail regeneration, and this was associated with increasing β-Catenin, p-Erk, 
p-Akt, and a reduction in cell mitosis and cell proliferation in the tail. These findings 
suggest that Wnt/ β-Catenin signaling regulates p-Erk and p-Akt signaling pathways 
to maintain cell mitosis and cell proliferative responses during axolotl tail 
regeneration. 
 
3.3 Methods 
3.3.1 Regeneration experiments 
Axolotl embryos were reared at 16°C in 40% Holtfreter’s solution. Embryos at 
developmental stage 42 (Bordzilovskaya & Dettlaff, 1989) were used for all tail 
regeneration experiments (Ponomareva et al. 2015). Wnt-C59 (Selleckchem, Cat. 
#S7037) was dissolved in DMSO at 10mM to make a stock solution and then diluted 
further to make a 10μM working solution. 0.1% DMSO was used for controls. 
Axolotl embryos were dechorionated and anesthetized in 0.02% benzocaine, and 2mm 
of tail tips were amputated using a sterile blade. Embryos were reared singly, one per 
well, in 12-well microtiter plates for dose-timing experiments and 
immunofluorescence (IF) staining. Five embryos were reared per well for tissue 
collection to perform Western Blotting experiments. There were 7 groups in the 
timing experiment: 0.1% DMSO control and Wnt-C59 administered from 0-12, 12-
24, 24-48, 48-72, 72-120, and 120-144hpa. The embryos were photographed at 
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different post-amputation time points. Tail length and snout-vent length were 
measured from the images. Statistical analyses were performed using GraphPad Prism 
software version 6.0 using Student’s t-test. 
 
3.3.2 Antibodies 
Anti-β-Catenin (Cat. # 610154) was purchased from BD Biosciences. Anti-Wnt3a 
(Cat. # bs-1700R), Anti-Erk (Cat. #4348), Anti-phospho-Erk (Thr202/Tyr204) (Cat. 
#4370), Anti-Akt (Cat. #9272), Anti-phospho-Akt (Ser473) (Cat. #9271), and Anti-β-
actin (Cat. #5125S) were purchased from Cell Signaling Technology. Anti-phospho-
Histone H3 (Ser10) (Cat. # 05-1336) was purchased from Millipore. Goat anti-Rabbit 
IgG, (H+L) HRP conjugate (Cat. # AP307P) and Goat anti-Mouse IgG, (H+L) HRP-
conjugated secondary antibodies (Cat. #AP308P) were purchased from Millipore. 
Cy3™ AffiniPure Donkey Anti-Mouse IgG (H+L) (Cat. #715-165-151) was 
purchased from Jackson immune Research. DAPI (4', 6-diamidino-2-phenylindole, 
dihydrochloride, Cat. #62247) was purchased from Thermo Scientific. 
 
3.3.3 Tissue processing and immunochemistry staining 
An existing protocol was modified for immunostaining (Qiu et al. 2015). In brief, 
samples were fixed in 4% paraformaldehyde overnight. Samples were dehydrated 
through a methanol series, starting in 100% PBS and then 25, 50, 75, and 100% 
methanol. These samples were saved at -20ºC for later use. Samples were rehydrated 
for whole-mount staining or OCT embedding. After OCT embedding, 8μM sections 
were prepared for staining or saved at minus 80°C for later use. Primary Anti-
phospho-Histone H3 (Ser10) antibodies were used at 1:1000, and the secondary 
Cy3™ AffiniPure Donkey Anti-Mouse IgG (H+L) antibodies were used at 1:200. 
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Blocking solution was modified as 5% sheep serum. Total DNA was labeled by 
DAPI. Stained slides were imaged using a confocal microscope (Nikon Tie and C2+ 
Confocal). A mitotic index was determined by dividing the number of histone H3 
positive cells by the number of DAPI positive cells within 200μm of the tail tip. 
Statistical analyses were performed using GraphPad Prism software version 6.0 using 
Student’s t-test. 
 
3.3.4 Western blotting 
Embryos were anesthetized with 0.02% benzocaine and 1mm of the distal tail tip was 
cut using a sterile blade. Tail tips of 30 embryos were pooled for each sample. Each 
pooled sample was washed two times using a 1x PBS solution with 
proteinase/phosphatase inhibitor mixture (#5872S, Cell Signaling Technology), and 
then lysed in RIPA buffer (#R0278, Sigma) with proteinase/phosphatase inhibitor 
mixture using a 22.5-gauge-needle and 1 ml syringe. Protein concentrations were 
determined by a BCA protein assay (#23225, Thermo Scientific). Equal amounts of 
tissue lysate were loaded into lanes of 10% SDS polyacrylamide gels and transferred 
to a PVDF membrane. The membranes were blotted with 5% non-fat milk, incubated 
overnight at 4°C with primary antibodies, and then incubated with HRP-conjugated 
secondary antibodies. The immune complexes were detected by enhanced 
chemiluminescence (Cat# NEL103001, PERKin Elmer). Quantification of band 
intensities was performed using the ImageJ software (http://rsbweb.nih.gov/ij/). The 
data were presented as the mean ± SD. Statistical analyses were performed using 
GraphPad Prism software version 6.0 using Student’s t-test. 
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3.3.5 EdU cell proliferation assay 
An EdU cell proliferation assay was performed using FAM picolyl azide from Click 
Chemistry Tools (Cat. # 1180-1), along with CuSO4 and sodium ascorbate in the 
Click-iTTM EdU Alexa FluorTM 488 Imaging Kit from Invitrogen (Cat. # C-10337).  
The protocol was modified for whole-mount staining and cryo-sections at 8µm. 
Briefly, axolotl embryos were tail amputated and placed in 12-well-plates with 0.1% 
DMSO or 10μM Wnt-C59 solution. At 48hpa, embryos were injected peritoneally 
with 1ul of 8μM 5-ethynyl-2’-deoxyuridine (EdU). At 72hpa, embryos were 
anesthetized and fixed in 4% paraformaldehyde overnight. The samples were 
dehydrated and rehydrated using a methanol series (0, 25, 50, 75, 100% in PBS). The 
samples were washed 3x with 1% Triton for 5 minutes, then bathed in 2.5% trypsin 
for 30 minutes, washed with ice-cold acetone for 10 minutes, followed by PBS and 
1% Triton 3x for 5 minutes. Click-iT EdU reaction solution containing 1x Tris- 
buffered saline, 4mM CuSO4, FAM 488 picolyl azide, and 100mM sodium ascorbate 
was used to visualize EdU incorporation into the DNA of proliferating cells. DAPI 
was used to stain total nuclear DNA. Cells staining positive for EdU within 400µm of 
the tail tip were counted as well as cells staining positive for DAPI within the same 
area. A proliferative index was calculated as a ratio of EdU positive cells to DAPI 
positive cells. Results were analyzed in GraphPad Prism software version 6.0 (San 
Diego California USA) using one-way ANOVA test. 
 
3.4 Results 
3.4.1 Blocking Wnt signaling prevents axolotl embryo tail regeneration. 
A Porcupine inhibitor, Wnt-C59, was previously demonstrated to inhibit axolotl tail 
regeneration using a 10μM dose (Ponomareva et al. 2015). To confirm this result and 
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titrate the best dosage, concentrations of Wnt-C59 at 0, 10-4, 10-3, 10-2, 10-1, 1, 2.5, 5, 
and 10μM were used to treat developmental stage 42 embryos. The treated embryos 
were healthy and active for all treatments tested. Doses of Wnt-C59 above 1μM 
inhibited tail regeneration at 168hpa (Figure 3.1, A and B). By varying the time of 
Wnt-C59 administration, I detected significant differences in tail length at 7dpa for 0-
12, 12-24, 24-48, 48-72, and 72-120hpa treatments. In contrast, I did not detect a 
significant difference in snout-vent length at 168hpa between the DMSO control and 
any treatment (Figure 3.1 D). The 120-144hpa group had shorter tails in comparison 
to the DMSO controls, but the difference was not statistically significant, presumably 
due to the short administration time. The above results indicate a requirement for Wnt 
signaling throughout most of the tail regeneration process. 
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Figure 3.1 Inhibiting Wnt signaling by Wnt-C59 blocks axolotl tail regeneration. A 
and B) Wnt-C59 above 1μM significantly inhibited axolotl embryo tail regeneration. 
C) 10µM of Wnt-C59 was administered for different lengths of time, and tail length 
was measured. Tail length at 168hpa differed significantly between DMSO control 
and Wnt-C59 treatments of 0-12, 12-24, 24-48, 48-72, and 72-120hpa. D) No 
significant differences in snout-vent length were detected between Wnt-C59 treated 
and DMSO control embryos. *: p-value < 0.05 for contrasts of DMSO control vs 
Wnt-C59, n = 4.  
 
3.4.2 Wnt3a is suppressed during tail regeneration. 
Previous studies have established that canonical Wnt/β-Catenin signaling promotes 
blastema formation and subsequent proliferation in zebrafish fin regeneration (Stoick-
Cooper et al. 2007). Wnt3a is a major Wnt ligand mediating Wnt/β-Catenin signaling. 
To evaluate if Wnt3a is also expressed during axolotl embryo tail regeneration, Wnt3a 
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was detected in pooled tail tips at 24, 48, and 72hpa. In comparison to pre-amputation 
levels, Wnt3a expression significantly decreased at 24hpa and 72hpa (Figure 3.2 A 
and B, p value < 0.05, n = 3). These data show dynamic changes in Wnt3a expression 
during the first 72 hours of tail regeneration.  
       
 Figure 3.2 Wnt3a expression decreases during tail regeneration. A) Wnt3a was 
detected by western blotting using pooled distal tail tips. β-Actin was blotted as a 
loading control. B) Wnt3a was expressed at 0hpa and decreased at 24hpa and 72hpa. 
*: p-value < 0.05 for contrasts between 0hpa vs 48hpa or 72hpa, n = 3. 
 
3.4.3 Wnt-C59 increases β-Catenin expression during tail regeneration.  
β-Catenin is an important transcription factor that mediates canonical Wnt/β-Catenin 
signaling. To investigate β-Catenin expression and determine how Wnt-C59 regulates 
β-Catenin levels, I quantified β-Catenin levels in regenerating distal tail tip tissues 
that were treated with DMSO or Wnt-C59 at 0, 24, 48, and 72hpa. β-Catenin was 
expressed at the time of amputation. Relative to pre-amputation levels, I detected a 
significant decrease in β-Catenin expression at 48hpa (Figure 3.2, p < 0.05, n = 3) and 
a significant increase in β-Catenin at 72hpa (Figure 3.3, p < 0.01, n = 3).  Wnt-C59 
increased β-Catenin at 48hpa (Figure 3.3, p < 0.01, n = 3). These results suggest that 
canonical Wnt signaling is dynamically changed during tail regeneration and β-
Catenin increases upon Wnt signaling pathway inhibition. 
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Figure 3.3 Wnt-C59 increases β-Catenin expression at 48hpa. A) β-Catenin was 
detected by western blotting using Wnt-C59 treated or DMSO control tails. β-Actin 
was blotted as a loading control. B) Relative to 0hpa, β-Catenin was significantly 
lower at 48hpa and significantly higher at 72hpa. Wnt-C59 increased β-Catenin 
expression at 48hpa. *: p-value < 0.05 for contrasts between DMSO control at 0hpa 
vs 48hpa or 72hpa, and between DMSO control and Wnt-C59 at 48hpa. 
 
3.4.4. Inhibiting Wnt signaling increases p-Erk and p-Akt expression. 
A few studies have shown that Wnt signaling regulates Erk or Akt signaling pathways 
(Zhang, Pizzute, and Pei 2014; Bikkavilli and Malbon 2009; Georgopoulos, 
Kirkwood, and Southgate 2014). To determine if Wnt signaling affects these 
pathways during axolotl tail regeneration, I detected p-Erk and p-Akt using distal 
pooled tail tips treated with Wnt-C59 and DMSO at 0, 24, 48, and 72hpa. Both p-Erk 
and p-Erk were expressed at the time of amputation but decreased at 24hpa and 
increased significantly at 72hpa (Figure 3.4, p < 0.001, n = 3). Wnt-C59 treatment 
increased p-Erk at all tested times and increased p-Akt expression at 48hpa and 72hpa 
(Figure 3.5, p < 0.001, n = 3). These results suggest that Wnt-C59 up-regulates Erk 
and Akt during tail regeneration.   
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Figure 3.4 Wnt-C59 increases phosphorylation of Erk at 24, 48, and 72hpa. A) P-Erk 
and Erk expression in Wnt-C59 treated and DMSO controls. B) P-Erk was lowly 
expressed at 0hpa and 24hpa but increased significantly at 48hpa and 72hpa. Wnt-C59 
treatment increased p-Erk expression at 24hpa, 48hpa, and 72hpa. *: p-value < 0.01 
for contrasts of DMSO control vs Wnt-C59, n = 3. 
 
 
Figure 3.5 Wnt-C59 increases phosphorylation of Akt at 48 and 72hpa. A) P-Akt and 
Akt expression in Wnt-C59 treated and DMSO controls. B) P-Akt was low at 0hpa. It 
significantly decreased at 24hpa and increased at 48hpa and 72hpa in regenerating tail 
tips. Wnt-C59 treatment significantly increased p-Akt expression at 48hpa and 72hpa. 
*: p value < 0.01 for contrasts of DMSO control vs Wnt-C59, n = 3. 
 
3.4.5 Wnt signaling regulates cell mitosis during axolotl tail regeneration. 
To determine if Wnt signaling regulates cell mitosis, a mitotic marker, anti-phospho-
histone H3 (Ser10), was used to stain mitotic cells in the tail using whole-mount 
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staining. Most of the phospho-histone H3 positive cells were located in the 
mesenchyme underlying the epidermis. The mitotic index of the DMSO control 
within 400µm of the distal tail tip was 7.5 ± 1.5%. Wnt-C59 treatment reduced the 
mitotic index by 2.5 ± 0.6% (Figure 3.6, p < 0.01, n = 3). These results show that Wnt 
signaling regulates cell mitosis in the distal tail tip during axolotl tail regeneration. 
 
  
 
Figure 3.6 Wnt-C59 inhibits the mitotic index at 48hpa.  A) DMSO control tail 
stained with phospho-histone H3 in red. The white stippled lines outline medial tail 
tissues to the exclusion of tail fins.  B) Wnt-C59 treated tail stained with phospho-
histone H3. C) Graph comparing the mitotic index in DMSO control and Wnt-C59 
treated tails. *: p-value < 0.05 for contrasts of DMSO control vs Wnt-C59. 
 
2.4.6 Wnt signaling regulates cell proliferation during axolotl tail regeneration. 
Wnt signaling is required for proliferation of progenitor cells in the blastema during 
zebrafish fin regeneration (Stoick-Cooper et al. 2007). To determine whether Wnt 
signaling regulates cell proliferation during axolotl tail regeneration, an EdU 
incorporation assay was used to detect proliferating cells from 48 to 72hpa. In DMSO 
treated samples, proliferating cells were observed in the regenerating tail, especially 
within 400μm of the tail tip (Figure 3.7 A-A’’), while Wnt-C59 treatment reduced 
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proliferating cells in the tail tip, dorsal fin, ventral fin, and spinal cord (Figure 3.7 B-
B’’, and D, n = 6, p < 0.001). These data show that Wnt signaling regulates cell 
proliferation during tail regeneration. Note that the proliferation index in the spinal 
cord of Wnt-C59 treated tails was still very high (44.8% ± 7.6%, n = 6).  
 
Embryos were reared without Wnt-C59 for 33 days to test for a long-term effect of 
early Wnt-C59 treatment. Interestingly, a fin-less phenotype was observed, consistent 
with a long-term block of fin regeneration. Moreover, Wnt-C59 treated animals did 
not develop forelimbs (Figure 3.8). This finding led me to investigate the Wnt 
signaling pathway during forelimb bud outgrowth, the results of which are presented 
in Chapter 5. 
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Figure 3.7 Wnt-C59 reduces cell proliferation.  Images A” and B” are cryo-sections of 
regenerating tails. All other images are the whole-mount and regenerating tails. A) 
DMSO control stained for EdU. A’) DMSO control stained with DAPI. A’’) DMSO 
control stained for EdU. B) Tail treated with Wnt-C59 and stained for EdU. B’) Tail 
treated with Wnt-C59 and stained with DAPI. B’’) Tail treated with Wnt-C59 and 
stained for EdU. C) Wnt-C59 significantly reduced cell proliferation. The 
proliferation index for the tail tip and spinal cord was determined from cryo-sections. 
For dorsal and ventral fin, proliferating cells were counted in whole-mount samples. 
*: p-value < 0.001 for contrasts of DMSO control vs Wnt-C59. 
62  
 
 
                                      
Figure 3.8 Wnt-C59 blocks dorsal and ventral fin regeneration and forelimb 
outgrowth permanently.  A) DMSO control with a fully regenerated tail at 33dpa. B) 
Amputated tail treated with Wnt-C59 for 7 days and reared to 33 days post tail 
amputation. The tail fins were not regenerated and no forelimb was observed. 
 
3.5 Discussion 
Wnt signaling pathway is required throughout axolotl tail regeneration. 
Wnt signaling is required for many different aspects of tissue regeneration 
(Kawakami et al. 2006; Ghosh et al. 2008; Shimokawa et al. 2013; Hamilton, Sun, 
and Henry 2016; Yokoyama et al. 2011; Sugiura et al. 2009; Lin and Slack 2008). The 
amputated tail is regenerated in 7 days. In this chapter, I blocked Wnt signaling by 
varying the time of Wnt-C59 application. I found that Wnt signaling was required 
from 0-120hpa, essentially the entirety of axolotl tail regeneration.  
 
β-Catenin and Wnt3a expression during axolotl tail regeneration 
β-Catenin is thought to be very important for tissue regeneration because β-Catenin 
induces limb regeneration in chick embryos that do not normally regenerate 
(Kawakami et al. 2006). β-Catenin is a dual function molecule that coordinates gene 
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transcription and also functions in cell-cell adhesion (Giarre, Semenov, and Brown 
1998). Cytosolic pools of β-Catenin enter the nucleus and modulate the expression of 
specific genes that regulate cell cycle progression (Giarre, Semenov, and Brown 
1998). The plasma membrane β-Catenin fraction acts as a component of cell-cell 
adhesion interactions that affect cell specification (Giarre, Semenov, and Brown 
1998). It is thought that Wnt-induced β-Catenin conformational changes favor 
assembly of transcriptional complexes that are key regulators of cell cycle progression 
to S phase (Harris and Peifer 2005; Giarre, Semenov, and Brown 1998). Globally 
blocking Wnt signaling pathway by Wnt-C59 did not block β-Catenin expression; in 
contrast, it increased β-Catenin expression at 48 and 72hpa. It has been shown that 
Wolffian lens regeneration in newt requires Wnt/β-Catenin signaling (Hayashi et al. 
2006), but Hamilton et al (2016) found that activation of Wnt signaling impairs 
cornea-lens regeneration which requires suppression of Wnt/β-Catenin signaling. 
These findings suggest that the requirement for Wnt/β-Catenin signaling depends on 
tissue type and mode of regeneration.  
 
I found that tail amputation decreased β-Catenin expression at 24hpa and 48hpa and 
increased β-Catenin at 72hpa. This suggests that β-Catenin levels are dynamically 
regulated during axolotl tail regeneration. This finding is consistent with a recent 
study that showed inhibition of tail regeneration using Wnt agonist II SKL, a 
compound thought to increase β-Catenin expression (Ponomareva et al. 2015). 
Moreover, Wnt agonist treatment before blastema formation inhibited Xenopus limb 
regeneration through inhibiting innervation, while treatment after blastema formation 
caused disorganization of skeletal features (Wischin et al. 2017). Amputated limbs 
treated with Wnt agonist at the onset of Xenopus limb regeneration did not form a 
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blastema (Wischin et al. 2017). It is also supported by similar findings in studies of 
Xenopus forelimb regeneration, where down-regulation of Wnt/β-Catenin signaling 
did not prevent limb regeneration (Yokoyama et al. 2011; Hamilton, Sun, and Henry 
2016). Furthermore, I found that Wnt3a was decreased at 24 and 72hpa, which further 
supports the idea that β-Catenin levels dynamically change upon tail amputation, and 
these changes are essential for successful tail regeneration.  
 
Upregulation of β-Catenin is associated with upregulation of Erk and Akt 
signaling in Wnt-C59 treated tails. 
In this study, I found that p-Erk and p-Akt were down-regulated at 24hpa but 
increased at 72hpa in regenerating tails. P-Erk levels were up-regulated by Wnt-C59 
at 24, 48 and 72hpa. P-Akt levels were upregulated by Wnt-C59 at 48 and 72hpa.  
High β-Catenin levels associated with high p-Akt and p-Erk levels in Wnt-C59 treated 
tails. Wnt signaling is known to affect Erk and/or Akt signaling in other models 
(Zhang, Pizzute, and Pei 2014). There is a positive feedback loop between Wnt and 
Erk pathways in which Erk activation upregulates β-Catenin through inactivation of 
Gsk-3β, and β-Catenin activates Raf1 through unknown mechanisms to activate Erk 
(Ding et al. 2005; Kim et al. 2007; Georgopoulos, Kirkwood, and Southgate 2014). 
While I observed similar changes in β-Catenin, p-Akt, and p-Erk, it remains to be 
shown how Wnt-C59-induced changes in the levels of these signaling molecules 
block axolotl tail regeneration. 
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Disruption of Wnt signaling differentially affects cell mitosis in proximal and 
distal regions of the tail. 
Broadly blocking Wnt signaling by Wnt-C59 reduced both cell mitosis and cell 
proliferation within 400μm of the distal tail tip. Thus, Wnt-C59 may inhibit tail 
regeneration by blocking cell proliferation that is necessary to reform tissues, which 
suggests that Wnts act as mitogens to control cell proliferation in the tail tip during 
axolotl tail regeneration. Interestingly, while I found that Wnt-C59 affected cell 
proliferation in medial and tail fin tissues, only the tail fin was permanently inhibited 
after discontinuation of Wnt-C59 treatment. Thus, Wnt-C59 provides a valuable new 
tool for regenerative biology because it can be used to decouple regeneration 
processes and investigate tissue-level differences in the requirement for Wnt 
signaling. In the absence of Wnt signaling during regeneration, progenitor cells in the 
tail fin mesenchyme are seemingly depleted, perhaps through mechanisms of cell 
death, quiescence, or differentiation. This hypothesis awaits further study. 
 
In summary, this study demonstrates the requirement of Wnt signaling during tail 
regeneration. Wnt inhibitor Wnt-C59 upregulated β-Catenin, p-Akt and p-Erk, and 
these changes were associated with a reduction in cell proliferation and mitosis of the 
regenerating tail tip. My findings suggest that temporal regulation of Wnt/β-Catenin is 
required for successful axolotl tail regeneration. 
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4.1 Abstract 
Fgf signaling plays an essential role during amphibian appendage regeneration, but its 
function during axolotl embryo tail regeneration is unknown. Here I used an Fgf 
receptor inhibitor (BGJ398) to disrupt Fgf signaling during axolotl tail regeneration. 
Concentrations of BGJ398 above 1μM inhibited tail regeneration. By varying the time 
of delivery of BGJ398, I found that Fgf signaling is critical during the first 12 hours 
of tail regeneration. Inhibition of Fgf signaling affected multiple molecular and 
cellular level processes during tail regeneration, including phosphorylation of Erk and 
Akt, Wnt3a/β-Catenin signaling, cell proliferation, and cell mitosis. The effect of 
BGJ398 was reversible as embryos that were initially treated with BGJ398 and then 
washed out fully regenerated their tails. These results show that Fgf signaling is 
required for axolotl tail regeneration.  
 
4.2 Introduction 
An axolotl embryo tail regeneration model was recently established to investigate 
signaling pathway mechanisms associated with tissue regeneration. Ponomareva et al. 
(2015) showed a requirement for Fgf signaling during tail regeneration by blocking 
Fgf-receptor function with a small molecule (BGJ398). Also, in that study, chemical 
inhibition of Wnt-ligand secretion using Wnt-C59 decreased transcription of 
fibroblast growth factor 9 (Fgf9). These results suggest that Fgf signaling is 
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downstream of Wnt signaling, as has been reported in other tissue regeneration 
models (Lin and Slack 2008; Love et al. 2013). In this chapter, I describe experiments 
that were performed to more rigorously establish that Fgf signaling is required for tail 
regeneration. 
 
Fgf signaling pathway plays roles in cell proliferation, mitogenesis, differentiation, 
angiogenesis, and embryogenesis (Ornitz and Marie 2015). There are 22 Fgf ligands 
grouped into seven subfamilies and four Fgf receptors (Fgfrs) in vertebrates (Dorey 
and Amaya 2010). Fgf signaling is initiated by binding of Fgf ligands to Fgfrs. A 
ligand-dependent dimerization event leads to the formation of a complex consisting of 
two Fgfs, two heparin sulfate chains, and two Fgfrs (Plotnikov et al. 1999). Each 
ligand binds to two receptors contacted with each other via a D2 domain, which 
results in the trans-phosphorylation of each receptor monomer (Schlessinger 2000). 
Upon the binding of Fgf ligands to receptors, the tyrosine residues on the docking 
protein Frs2-alpha are phosphorylated (Hadari et al. 2001). Two downstream 
pathways associated with Fgf signaling pathway are the Ras/Map kinase pathway and 
the PI3/Akt pathway (Armstrong et al. 2006). The Ras/Map kinase pathway is 
associated with many biological processes, including cellular proliferation and 
differentiation (Shapiro 2002). Map kinase effectors include Erk, c-Jun N-terminal 
kinase (Jnk), and p38 mitogen-activated kinase (Cargnello and Roux 2011). The 
PI3k/Akt pathway is also associated with many biological processes, including cell 
survival and cell fate determination (Yu and Cui 2016).  
 
Several Fgf ligands have been shown to play key roles in tissue regeneration. Fgf 
signaling factors are considered neurotrophic factors because they are expressed in 
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nerve tissue during axolotl limb regeneration and promote blastema formation and 
outgrowth (Mullen et al. 1996; Satoh et al. 2011). Fgf8 is expressed in the basal layer 
of the AEC during blastema formation, and Fgf8 and Fgf10 are upregulated in 
underlying mesenchymal cells. Fgf8 is expressed in the anterior mesenchyme and its 
expression depends on sonic Hedgehog (Shh) signaling from posterior tissue during 
axolotl limb regeneration. Ectopic Fgf8 and endogenous Hh signaling are sufficient to 
induce axolotl limb regeneration from cells of a posterior blastema (Nacu et al. 2016). 
Consistent with the idea that Fgfs are neurotrophic factors, denervation of the limb 
prevents Fgf8 and Fgf10 upregulation during axolotl limb regeneration (Kolodziej et 
al. 2001; Han et al. 2001). Fgf2 and Fgf8, together with growth and differentiation 
factor-5 (Gdf5), are sufficient to substitute nerve induction of limb and tail 
regeneration in urodele amphibians (Makanae et al. 2013).  
 
In this study, I examined Fgf signaling pathway components during axolotl tail 
regeneration. Disruption of Fgf signaling by BGJ398 inhibited tail regeneration. 
Interestingly, BGJ398 treatment upregulated both Wnt3a and β-Catenin. Under the 
assumption that Fgf signaling is regulated by Wnt signaling, this suggests that Fgf 
signaling activity regulates Wnt ligand expression. BGJ398 treatment also 
downregulated Erk signaling, upregulated Akt signaling, and reduced cell 
proliferation and mitosis.  
 
4.3 Methods 
4.3.1 Regeneration experiments 
Axolotl embryos were reared at 16°C in 40% Holtfreter’s solution. Embryos at 
developmental stage 42 (Bordzilovskaya & Dettlaff, 1989) were used for all the tail 
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regeneration experiments (Ponomareva et al. 2015). BGJ398 (Selleckchem, Cat. 
#S2183) was dissolved in DMSO to make a 10mM stock solution and then diluted 
further to make 10μM working solutions. DMSO at 0.1% was used for controls. 
Axolotl embryos were dechorionated and anesthetized in 0.02% benzocaine, and 2mm 
of the distal tail tip was amputated using a sterile blade. Embryos were reared singly, 
one per well, in 12-well microtiter plates for the timing experiments and 
immunofluorescence (IF) staining. Five embryos were reared per well for tissue 
collection to perform Western blotting experiments. There were 7 groups in the 
timing experiment: 0.1% DMSO control, and 10μM Wnt-C59 administered from 0-
12, 12-24, 24-48, 48-72, 72-120, and 120-144hpa. The embryos were photographed at 
different post-amputation times. Tail length and snout-vent length were measured 
from the images. Statistical analyses were performed using GraphPad Prism software 
version 6.0 using Student’s t-test. 
 
4.3.2 Antibodies 
Anti-Erk (Cat. #4348), Anti-phospho-Erk (Thr202/Tyr204) (Cat. #4370), Anti-Akt 
(Cat. #9272), Anti-phospho-Akt (Ser473) (Cat. #9271), and Anti-β-Catenin (Cat. # 
610154) were purchased from BD Biosciences. Anti-Wnt3a (Cat. # bs-1700R) was 
obtained from Bioss Antibodies. Anti-β-actin (Cat. #5125S) was purchased from Cell 
Signaling Technology. Anti-phospho-Histone H3 (Ser10) (Cat. # 05-1336) was 
purchased from Millipore. Goat anti-Rabbit IgG, (H+L) HRP conjugate (Cat. # 
AP307P) and Goat anti-Mouse IgG, (H+L) HRP-conjugated secondary antibodies 
(Cat. #AP308P) were purchased from Millipore. Cy3™ AffiniPure Donkey Anti-
Mouse IgG (H+L) (Cat. #715-165-151) was purchased from Jackson Immune 
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Research. DAPI (4', 6-diamidino-2-phenylindole, dihydrochloride, Cat. #62247) was 
purchased from Thermo Scientific. 
 
4.3.3 Tissue processing and immunochemistry staining 
An existing protocol was modified for cryosection immunostaining (Qiu et al. 2015). 
In brief, samples were fixed in 4% paraformaldehyde (PFA) overnight. Samples were 
dehydrated through a methanol series, starting in 100% PBS and then 25, 50, 75, and 
100% methanol. These samples were saved at -20ºC for later use. The samples were 
rehydrated for whole-mount staining or OCT embedding. After OCT embedding, 
8μM sections were prepared for staining or saved at -80°C for later use. Primary Anti-
phospho-Histone H3 (Ser10) was used at 1:1000, and the secondary Cy3™ AffiniPure 
Donkey Anti-Mouse IgG (H+L) was used at 1:200. Blocking solution was modified 
as 5% sheep serum. Total DNA was labeled by DAPI. Stained slides were imaged 
using a confocal microscope (Nikon Tie and C2+ Confocal). A mitotic index was 
determined by dividing the number of histone H3 positive cells by the number of 
DAPI positive cells within 200μm. Statistical analysis was performed using GraphPad 
Prism software version 6.0 using Student’s t-test. 
 
4.3.4 Western blotting 
Embryos were anesthetized with 0.02% benzocaine and then 1mm of the distal tail tip 
was cut using a sterile blade. Tail tips of 30 embryos were pooled for each sample. 
The pooled tail tips were washed 2x using 1x PBS solution with 
proteinase/phosphatase inhibitor mixture (#5872S, Cell Signaling Technology), and 
then tissue was lysed in RIPA buffer (#R0278, Sigma) with proteinase/phosphatase 
inhibitor mixture by using a 22.5-gauge-needle and 1 ml syringe. Protein 
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concentrations were determined by a BCA protein assay (#23225, Thermo Scientific). 
Equal amounts of tissue lysate were loaded into lanes of 10% SDS polyacrylamide 
gels and transferred to a PVDF membrane. The membranes were blotted with 5% 
non-fat milk and then incubated overnight at 4°C with primary antibodies. After this, 
membranes were treated with HRP-conjugated secondary antibodies. The immune 
complexes were detected by enhanced chemiluminescence (Cat# NEL103001, 
PerkinElmer). Quantification of band intensities was performed using ImageJ 
software (http://rsbweb.nih.gov/ij/). Statistical analyses were performed using 
GraphPad Prism software version 6.0 using Student’s t-test. 
 
4.3.5 EdU cell proliferation assay 
An EdU cell proliferation assay was performed using FAM picolyl azide from Click 
Chemistry Tools (Cat. # 1180-1), along with CuSO4 and sodium ascorbate in the 
Click-iTTM EdU Alexa FluorTM 488 Imaging Kit from Invitrogen (Cat. # C-10337).  
The protocol was modified for whole-mount staining and cryo-sections at 8μm. 
Briefly, axolotl embryos were tail amputated and placed in 12-well-plates with 0.1% 
DMSO or 10μM BGJ398 solution. At 48hpa, embryos were injected peritoneally with 
1ul of 8μM 5-ethynyl-2’-deoxyuridine (EdU). At 72hpa, embryos were anesthetized 
with 0.02% benzocaine and fixed in 4% paraformaldehyde overnight. The samples 
were dehydrated and rehydrated using a methanol series (0, 25, 50, 75, 100% in PBS). 
The samples were washed 3x with 1% Triton for 5 minutes, then bathed in 2.5% 
trypsin for 30 minutes, washed with ice-cold acetone for 10 minutes, followed by PBS 
and 1% Triton 3x for 5 minutes. Click-iT EdU reaction solution containing 1x Tris- 
buffered saline, 4mM CuSO4, FAM 488 picolyl azide, and 100mM sodium ascorbate 
was used to visualize EdU incorporation into the DNA of proliferating cells. DAPI 
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was used to counter stain the samples. Cells staining positive for EdU within 400μm 
of the tail tip were counted as well as cells staining positive for DAPI within the same 
area. A proliferative index was calculated as the ratio of EdU positive cells to DAPI 
positive cells. Results were analyzed in GraphPad Prism software version 6.0 (San 
Diego California USA) using one-way ANOVA. 
 
4.4 Results 
4.4.1 Blocking Fgf signaling inhibits axolotl embryo tail regeneration. 
BGJ398, a potent inhibitor of Fgf signaling, was previously shown to inhibit axolotl 
tail regeneration in a chemical genetic screen (Ponomareva et al. 2015). Here I more 
rigorously investigated timing and dosage of BGJ398 during axolotl tail regeneration. 
Concentrations of BGJ398 at 0, 10-4, 10-3, 10-2, 10-1, 1, 2.5, 5, and 10µM were used to 
treat developmental stage 42 axolotl embryos. The treated embryos were healthy and 
active within all treatment groups. Concentrations of BGJ398 above 1μM 
significantly inhibited tail regeneration at 7 days post tail amputation (dpa). By 
varying the time of BGJ398 administration, I detected a significant difference in tail 
length at 7dpa for the 0-12hpa treatment group compared with DMSO controls. 
Interestingly, I observed cup-shaped tails that folded anteriorly in 1, 2.5, and 5µM 
BGJ398 treated tails, a phenotype described by Voss et al. (2019) (Figure 4.1 A). 
These results establish that Fgf signaling is required for tail regeneration and the 
critical time for Fgf signaling is 0-12hpa.  
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Figure 4.1 Blocking Fgf receptors prevents axolotl embryo tail regeneration. A) and 
B) BGJ398 above 1μM significantly inhibited axolotl embryo tail regeneration. C) 
10μM of BGJ398 was administered for different periods, and the tail length was 
measured. Tail length at 7dpa differed significantly between DMSO control and the 0-
12hpa BGJ398 treatment. D) No significant difference in snout-vent length was 
detected between BGJ398 treated and DMSO control embryos. *: p-value < 0.05 for 
contrasts of DMSO control vs Wnt-C59. 
  
4.4.2 BGJ398 downregulates phosphorylation of Erk. 
Upon Fgf ligand binding, Fgfr activates downstream signaling cascades, including the 
Mapk/Erk signaling pathway (Mukerjee 1947). To determine if Fgf/Erk signaling is 
activated during axolotl tail regeneration, I quantified phosphorylated Erk (p-Erk) 
expression by Western blotting. In DMSO control embryos, p-Erk was detected at the 
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time of amputation and increased at 24hpa (Figure 4.2, p-value < 0.001, n = 3). After 
this time, p-Erk levels at 48hpa (Figure 4.2, p-value < 0.05, n = 3), but not 72hpa 
(Figure 4.2, p-value > 0.05, n = 3), were significantly higher than basal (day0) levels. 
A similar pattern of expression was observed for embryos treated with continuous 
BGJ398 treatment. However, the spike in p-Erk at 24hpa was significantly lower than 
that observed in controls (Figure 4.2, p-value < 0.01, n = 3). These results show that 
inhibition of Fgf signaling reduces p-Erk at 24hpa. 
  
 
Figure 4.2 BGJ398 decreases phosphorylation of Erk at 24hpa. A) P-Erk and Erk 
were detected by Western blotting using pooled 1mm tail tips from BGJ398 treated or 
DMSO control embryos at 0, 24, 48, and 72hpa. B) P-Erk expression was normalized 
against Erk. *: p-value < 0.01 for contrast of DMSO control vs BGJ398. 
  
4.4.3 BGJ398 upregulates phosphorylation of Akt. 
Activated Fgf receptors also regulate the Akt pathway, which promotes cell survival 
and growth (Yu and Cui 2016). To determine if Fgf/Akt signaling is activated during 
axolotl tail regeneration, I quantified phosphorylated Akt (p-Akt) expression. In 
DMSO control embryos, p-Akt was detected at the time of amputation and decreased 
at 24hpa (Figure 4.3, p = 0.053, n = 3). Between 24-48hpa, p-Akt levels increased, 
roughly approximating basal levels. After this time, levels decreased at 72hpa. This 
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complex temporal pattern was also observed in embryos treated continuously with 
BGJ398. However, p-Akt levels were significantly higher in BGJ398 treated embryos 
than controls at 48hpa and 72hpa (Figure 4.3, p-value < 0.05, n = 3). These results 
show that Akt phosphorylation is dynamically regulated during tail regeneration and 
inhibition of Fgf signaling increases p-Akt at 48 and 72hpa.  
 
Figure 4.3 BGJ398 downregulates phosphorylation of Akt. A) P-Akt and Akt were 
detected by Western blotting using pooled 1mm tail tips from BGJ398 treated or 
DMSO control embryos at 0, 24, 48, and 72hpa. B) P-Akt expressions were 
normalized against Akt. *: p-value < 0.05 for contrast of DMSO control vs BGJ398.  
 
4.4.4 BGJ398 upregulates Wnt/β-Catenin signaling. 
The Wnt/β-Catenin and Fgf signaling pathways are required for zebrafish fin 
regeneration and Xenopus limb regeneration, and in both cases, Wnt/β-Catenin 
signaling acts upstream of Fgf signaling (Poss et al. 2000; Yokoyama et al. 2007; 
Stoick-Cooper et al. 2007). To test if Fgf signaling affects Wnt/β-Catenin signaling 
during tail regeneration, Wnt3a and β-Catenin were detected by western blotting. 
Wnt3a was detected at the time of tail amputation, decreased at 24hpa, and 
approximated basal (day0) levels at 48 and 72hpa (Figure 4.6, p-value < 0.05, n = 3). 
β-Catenin was also expressed at the time of tail amputation and increased at 72hpa 
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(Figure 4.6, p-value < 0.05, n = 3). Continuous BGJ398 treatment increased Wnt3a at 
48 and 72hpa, and increased β-Catenin at 48hpa (Figure 4.6, p-value < 0.05, n = 3). 
These data show that BGJ398 inhibition of Fgf signaling increases the expression of 
Wnt ligands.    
 
Figure 4.4 BGJ398 upregulates Wnt ligand expression. A) Wnt3a, β-Catenin, and β-
Actin were detected by Western blotting using pooled 1mm tail tips from BGJ398 
treated or DMSO control embryos at 0, 24, 48, and 72hpa. B) Wnt3a expression was 
normalized against total β-Actin. BGJ398 increased Wnt3a expression at 48hpa and 
72hpa. B) β-Catenin expression was normalized against β-Actin. BGJ398 increased β-
Catenin expression significantly at 48hpa. *: p-value < 0.05 for contrast of DMSO 
control vs BGJ398.  
 
4.4.5 Fgf signaling regulates cell mitosis during axolotl tail regeneration. 
Fgf signaling sustains progenitor cell mitogenic activity during zebrafish fin 
regeneration and muscle regeneration (Shibata et al. 2016; Saera-Vila, Kish, and 
Kahana 2016). To determine if Fgf signaling is similarly needed to sustain mitogenic 
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activity during axolotl tail regeneration, anti-phospho-histone H3 (Ser10) staining was 
performed to identify mitotic cells at 48hpa.  Approximately twice (7.5± 1.5%) as 
many mitotic cells were observed in DMSO control versus BGJ398-treated embryos 
(Figure 4.5, p < 0.05, n = 3). These results suggest that Fgf signaling is required to 
sustain cell mitosis during axolotl tail regeneration. 
      
Figure 4.5 BGJ398 inhibits mitosis in axolotl tails at 48hpa. A) DMSO control tail 
stained with phospho-histone H3. The white stippled lines outlined the tail. The other 
tissues are fins. B) BGJ398 treated tail stained with phospho-histone H3. C) Graph 
comparing the mitotic index in DMSO control and BGJ398 treated tails (n = 3 
embryos). *: p-value < 0.05 for contrast of DMSO control vs BGJ398. 
 
4.4.6 BGJ398 reduces the number of cells in S-phase. 
Fgf signaling is required for cell proliferation of blastema cells during zebrafish tail 
regeneration (Shibata et al. 2016). To determine if Fgf signaling regulates cell 
proliferation during axolotl tail regeneration, an EdU incorporation assay was used to 
detect S-phase cells at 72hpa. BGJ398 treatment reduced proliferating cells in the tail 
tips, dorsal fins, and ventral fins (Figure 4.6, p < 0.001, n = 6), but not the spinal cord 
(Figure 4.6, p > 0.05, n = 6). These results suggest that Fgf signaling regulates cell 
proliferation in the tail tip and fins during axolotl tail regeneration.  
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Figure 4.6 BGJ398 reduces S-phase entry of cells in the tail but not the spinal cord. 
Image A’’ and B’’ are cryo-sections of regenerating tails. Images in panels C-D are 
whole-mounts.  A) DMSO control stained with EdU A’) DMSO control stained with 
DAPI A’’) DMSO control stained with EdU and DAPI. B) Tail treated with BGJ398 
and stained with EdU. B’) Tail treated with BGJ398 and stained with DAPI. B’’) Tail 
treated with BGJ398 and stained with EdU and DAPI. C) The proliferative index for 
tail tissues was estimated from counted cells in cryo-sections due to the thickness of 
the tail. For dorsal and ventral fins, cells were counted in whole-mount preparations. 
BGJ398 reduced cell proliferation of the tail except for the spinal cord. D) An image 
with labeled tissue types. E) Full tail regeneration at 12dpa of an embryo treated for 7 
days with BGJ398. *: p-value < 0.05 for contrast of DMSO control vs BGJ398. 
 
4.5 Discussion 
The results in this chapter show that Fgf signaling pathway is required for axolotl tail 
regeneration. Embryos that were treated with BGJ398, a small molecule inhibitor of 
Fgf signaling did not regenerate their tail. In addition to blocking tail regeneration, 
BGJ398 reduced p-Erk levels at 24hpa and increased p-Akt at 48hpa and 72hpa. 
These pathways are known to regulate many biological processes, including cell 
division and growth, and embryos treated with BGJ398 presented fewer S-phase and 
mitotic phase cells, consistent with inhibition of cell proliferation.  
 
Fgf signaling inhibitor BGJ398 acts during the first 12 hours of tail regeneration.  
By varying the time that BGJ398 was administered to embryos, I identified a 12hr 
post-amputation window of time within which Fgf signaling is required for successful 
tail regeneration. This was an unexpected finding because Fgf signaling is thought to 
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be activated downstream of Wnt signaling, which is activated after this time. For 
example, I showed in Chapter 3 that Wnt ligands were not up-regulated until at least 
48hpa, and in Ponamareva et al (2015), Wnt pathway target genes were not 
differentially expressed between Wnt-C59 treated and control axolotl embryos until 
24 hpa. Thus, it seems likely that Fgf signaling is regulated independently of Wnt 
signaling, at least during the first 12 hours of regeneration. It is tempting to think that 
during this interval of time, Fgf signaling is required for proper formation of the 
wound epithelium, as is known for zebrafish fin regeneration (Whitehead et al. 2005). 
Studies of axolotl limb regeneration have shown that the basal layer of the wound 
epithelium, and underlying mesenchymal cells, secrete Fgf ligands that support 
progenitor cell proliferation (Mullen et al. 1996; Satoh et al. 2011). Perhaps, if the 
wound epithelium does not develop competence for Fgf ligand secretion during the 
first 12 hours of regeneration, activated progenitor cells are stalled in the cell cycle 
until the Fgf signaling block is released. After 12 hours, progenitor cell proliferation 
may no longer depend upon Fgf signaling. In other words, cells gain autonomy for 
cell proliferation after 12hpa, in much the same way that progenitor cells of 
regenerating limbs escape nerve-dependency at later stages of blastema maturation 
(Kumar et al. 2007; McCusker, Bryant, and Gardiner 2015). This hypothesis is 
consistent with the results of this study, including the reversibility of BGJ398 
inhibition of Fgf signaling. 
 
Erk and Akt signaling pathways during axolotl tail regeneration 
In control embryos, Erk phosphorylation was significantly increased at 24hpa and 
high levels were sustained at 48hpa and 72hpa. BGJ398 treatment significantly 
decreased Erk phosphorylation at 24hpa. Erk phosphorylation is required for re-entry 
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of post-mitotic newt muscle cells by downregulation of P53 activity, while only 
transient Erk activation is observed in mammalian counterparts (Yun, Gates, and 
Brockes 2014). Although muscle de-differentiation and cell cycle entry do not occur 
in axolotls, differential changes in Erk signaling may be associated with cell cycle 
regulation. Indeed, fewer M-phase and S-phase cells were observed in BGJ398 treated 
embryos. Akt phosphorylation was decreased at 24hpa in DMSO control embryos and 
BGJ398 treatment increased Akt phosphorylation at 48 and 72hpa. Since the PI3k/Akt 
pathway plays a role in cell fate determination (Yu and Cui 2016), suppression of Akt 
phosphorylation during regeneration, as was observed in control embryos, may 
sustain progenitor cell proliferation. This hypothesis awaits further study. 
 
BGJ398 upregulates Wnt/β-Catenin signaling pathway. 
Inhibition of Fgf signaling by BGJ398 was associated with a significant increase in 
Wnt3a and β-Catenin expression at 48 and 72hpa. This suggests that regulation of 
Wnt/β-Catenin signaling may depend upon the activity state of the Fgf pathway. 
When Fgf signaling activity is dampened, β-Catenin mediated signaling increases to 
return Fgf signaling to basal levels under homeostatic conditions, or levels needed to 
support proliferating cells during tail regeneration. Such a model is consistent with the 
hierarchical regulation of Fgf signaling by canonical Wnt signaling during later 
phases of regeneration when cell proliferation and tail outgrowth are maximal. My 
results enrich this model by implicating a feedback mechanism between these two 
pathways. However, Fgfr1 antagonist SU-5402 decreased Wnt3a expression during 
Xenopus tail regeneration (Lin and Slack 2008). This may reflect a species-specific 
difference between axolotls and Xenopus, a difference in the action of Fgf inhibitors 
between studies, or a limitation of feed-back regulation to β-Catenin-mediated Wnt 
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signaling in Xenopus. Overall, my results suggest that Fgf and Wnt signaling 
pathways interact to regulate cell proliferation during axolotl tail regeneration. 
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5.1 Abstract 
Wnt signaling pathway and Fgf signaling pathway are key regulators of limb 
development in vertebrates such as chicken and mice. How Wnt and Fgf signaling 
pathways regulate forelimb bud outgrowth in the axolotl (Ambystoma mexicanum) is 
unknown. Here I demonstrate that Wnt signaling is required for forelimb bud 
development in the Mexican axolotl. Inhibiting Wnt signaling by Wnt-C59 prevented 
forelimb bud development. The critical window for inhibition was approximately 
developmental stage 40-42. Expression of canonical Wnt signaling ligand Wnt3a and 
cell polarity marker Zo1 were significantly decreased in epidermal cells of the 
forelimb bud in Wnt-C59 treated forelimbs. Moreover, Wnt-C59 treatment appeared 
to disrupt the orientation and density of mesodermal cells in the forelimb bud and 
significantly decreased mesodermal cell proliferation and mitosis. The results of this 
study indicate a requirement for Wnt signaling during forelimb bud development in 
the axolotl.  
 
5.2 Introduction 
Vertebrate limb development is a classic model for investigating patterning of three-
dimensional structures during organ embryogenesis (Towers and Tickle 2009; Yang 
2003). Three axes are used to characterize limb structure: a proximal-distal axis (P-D 
axis) runs along the arm from shoulder to digits; an anterior-posterior axis (A-P axis), 
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runs from the thumb to the little finger; and a dorsal-ventral axis (D-V axis), runs 
from the back of the hand to the palm. Three major signaling centers direct limb 
development along these axes. The first signaling center to appear during limb 
development is the apical ectodermal ridge (AER), which forms as a thickened 
epithelial cell layer at the distal part of the early limb bud. Fibroblast growth factors 
(Fgfs) in the AER are sufficient and necessary for AER function in proximal-distal 
limb outgrowth and patterning (Mariani, Ahn, and Martin 2008; Saunders 1998; 
Niswander and Martin 1993). The second signaling center is the zone of polarizing 
activity (ZPA). Sonic Hedgehog (Shh) signaling from the ZPA regulates anterior-
posterior patterning (Ogura et al. 1996). The third signaling center is the non-AER 
limb ectoderm. The limb ectoderm produces molecules which are essential for dorsal 
( e.g., Wnt7a: (Riddle et al. 1995) and ventral (e.g., Engrailed-1: (Loomis et al. 1996) 
patterning. Signaling from the AER, ZPA, and limb ectoderm are crucial for the 
formation of a limb with correct axial polarity (Tickle 2015). 
 
Several signaling pathways (such as the Wnt signaling pathway, Fgf signaling 
pathway, retinoid acid signaling pathway, and Bmp signaling pathway) and 
transcription factors (Tbx4, Tbx5, Pitx1, Nf-kappaB, Hoxb13, and Hoxc10) have been 
associated with limb patterning (Carlson et al. 2001; Bushdid et al. 1998; Kanegae et 
al. 1998; Grandel and Brand 2011; Kawakami et al. 2001; Christen et al. 2012; Duboc 
and Logan 2011). These signaling pathways must be tightly regulated spatially and 
temporally to ensure limb bud outgrowth. A hallmark of early vertebrate limb 
development is the limb bud. Limb bud outgrowth depends on signaling from the 
AER (Hamburger and Hamilton 1992). A regulatory loop consisting of Wnt factors 
Wnt3a, Wnt2b and Wnt8c, and fibroblast growth factors Fgf8 and Fgf10, play a key 
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role in both AER induction and limb bud outgrowth (Kawakami et al. 2001). Wnt3a is 
the earliest known AER marker during chick limb development. It signals through the 
canonical β-Catenin pathway and mediates Fgf10 to induce Fgf8 expression in the 
limb ectoderm during AER formation in the chick (Kengaku et al. 1998; Kawakami et 
al. 2001). It is thought that the limb bud is defined by a temporal succession of 
signaling events. For example, Christen et al. (2012) demonstrated that retinoic acid 
from somites specifies the limb field by activating Wnt ligands (wnt2b in forelimb 
and wnt8c in hindlimb) in the intermediate mesoderm, which is followed by the 
expression of tbx5 and tbx4 in the lateral plate mesoderm at positions where fore- and 
hind limb develop, respectively. Fgf10 signaling from the mesoderm to the overlaying 
ectoderm then induces the formation of the apical epidermal ridge, thereby 
establishing a signaling center for proximal-distal limb outgrowth (Christen et al. 
2012). These data suggest that Wnt signaling plays an essential during early limb 
development. 
 
The “proliferation gradient” model has been the most prominent hypothesis of 
physical morphogenesis of limb bud outgrowth, first proposed by Ede and Law (Ede 
and Law 1969). They proposed that a mitogen released by the AER signals underlying 
mesodermal cells to proliferate and form a P-D progress or proliferation zone (Reiter 
and Solursh 1982). There is another hypothesis explaining limb bud morphogenesis: 
oriented cell divisions, which has been found during limb bud extension (Wyngaarden 
et al. 2010). To achieve uniform polarity, mesodermal cells of the limb bud must 
employ a mechanism establishing and coordinating polarized cell behaviors along 
their developmental axes (Gao and Yang 2013). Wnt5a signaling gradients establish 
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planar cell polarity in chondrocytes along the P-D axis via Vangl2 phosphorylation 
(Gao and Yang 2013).  
 
Although many studies have shown the importance of Wnt signaling during vertebrate 
limb development, little is known about Wnt signaling during forelimb bud 
development in the axolotl. In this study, a Porcupine inhibitor, Wnt-C59, was used to 
show a requirement for Wnt signaling during forelimb bud development in the 
axolotl. 
 
5.3 Methods 
5.3.1 Animal husbandry and timing experiments for limb bud outgrowth. 
Axolotl embryos were reared at 16°C in 40% Holtfreter’s solution. Embryos at 
developmental stage 40 (Bordzilovskaya & Dettlaff, 1989) were used for all 
experiments. Wnt-C59 (Selleckchem, Cat. #S7030) was dissolved in DMSO to make 
a 10mM as stock solution and then diluted further to make 10μM working solutions 
(DaCosta Byfield et al. 2004). NVP-BGJ398 (Selleckchem, Cat. #S2183) was 
dissolved in DMSO at 10mM and then diluted to 10μM for regeneration experiments 
(Denis et al. 2016). DMSO at 0.1% was used as a control. Axolotl embryos were 
dechorionated one day before the embryos reached developmental stage 40. In the 
timing experiment for limb bud outgrowth, a total of 155 axolotls were divided into 
30 treatment groups plus one 0.1% DMSO control group. Each Wnt-C59 treated 
group was treated for three days, thus providing an overlapping series of treatments 
throughout the time course of forelimb development (Figure 5.1). The axolotls were 
anesthetized in 0.02% benzocaine and photographed 33 days after developmental 
stage 40. A few controls and Wnt-C59 treated animals (Day1-3 treatment group) were 
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reared to approximately one year of age. At this time, they were anesthetized and then 
photographed. Three aurora kinase inhibitors, CYC116, MK-5108, and Danusertib at 
10mM in DMSO solution were obtained from Dr. Jon Thorson’s Lab and were diluted 
further to make 10μM working solutions. The stage 40 embryos were treated 
separately with the three aurora kinase inhibitors for 7 days, and then washed out and 
reared for another 7 days, at which time they were photographed. 
 
5.3.2 Antibodies 
Rabbit anti-Wnt3a antibodies were obtained from bioss (Cat. # bs-1700R). Rabbit 
anti-Zo1 (Cat. #61-7300) was purchased from Invitrogen. Anti-phospho-Histone H3 
(Ser10) (Cat. # 05-1336) was purchased from Millipore. Cy3™ AffiniPure Donkey 
Anti-Mouse IgG (H+L) (Cat. #715-165-151) was purchased from Jackson immune 
Research. DAPI (4', 6-diamidino-2-phenylindole, dihydrochloride, Cat. #62247) was 
purchased from Thermo Scientific. 
 
5.3.3 H& E staining and immunochemistry staining 
An existing protocol was modified for immunostaining (Qiu et al. 2015). In brief, 
samples were fixed in 4% paraformaldehyde (PFA) overnight. Samples were 
dehydrated through a methanol series, starting in 100% PBS and move up through 25, 
50, 75, and 100% methanol. These samples were used freshly or saved at -20ºC for 
later use. Samples were rehydrated for whole-mount staining or OCT embedding. 
After OCT embedding, 8μM sections were prepared at D-V/P-D plane or A-P/P-D 
plane of forelimb bud for staining or saving at -80°C for later use. For H&E staining, 
sections were stained using filtered hematoxylin (VWR, # 95057-844) and 0.5% 
Eosin and mounted with Permount (Fisher Chemical, #. SP15-100). For 
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immunochemistry staining, epitope retrieval was done by heating in 10mM Tris-HCl 
solution (pH 9.5) on a hot plate. Primary Anti-phospho-Histone H3 (Ser10) antibodies 
were used at 1:1000. Anti-Zo1 and anti-Wnt3a antibodies were used at 1:100. The 
secondary Cy3™ AffiniPure Donkey Anti-Mouse IgG (H+L) antibodies were used at 
1:200. Blocking solution was modified into 5% sheep serum. Total DNA was labeled 
by DAPI. Stained slides were imaged using a confocal microscope (Nikon Tie and 
C2+ Confocal). A mitotic index was determined by dividing the number of histone 
H3 positive mesodermal cells by the number of DAPI positive mesodermal cells 
within the limb bud. Results were analyzed in GraphPad Prism software version 6.0 
using Student’s t-test. 
 
5.3.4 EdU cell proliferation assay 
An EdU cell proliferation assay was performed using FAM Picolyl Azide from Click 
Chemistry tools (Cat. # 1180-1), and CuSO4 and Sodium Ascorbate in the Click-iTTM 
Edu Alexa FluorTM 488 Imaging Kit (Invitrogen, Cat. # C-10337). The protocol was 
modified for whole-mount 5-ethynyl-2’-deoxyuridine (EdU) staining or cryo-section 
staining. Briefly, axolotl embryos were placed in 12-well-plates with 0.1% DMSO 
(control) or 10μM Wnt-C59. At 24 hours post-treatment, embryos were injected 
peritoneally with 1ul of 8μM EdU. At 72 hours post-treatment, embryos were 
anesthetized with 0.02% benzocaine and fixed in 4% paraformaldehyde overnight. 
The samples were dehydrated and rehydrated using a methanol series (0, 25, 50, 75, 
and 100% in PBS). The samples were washed 3x with PBS with 1% Triton for 5 
minutes, then bathed in 2.5% trypsin for 30 minutes, washed 3x with PBS with 1% 
Triton for 5 minutes, and finally washed with ice-cold acetone for 10 minutes. Click-
iT EdU reaction solution containing 1x Tris-buffered saline, 4mM CuSO4, FAM 488 
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picolyl azide, and 100mM sodium ascorbate was used to visualize EdU incorporation 
into the DNA of proliferating cells. DAPI was used to counter stain the samples. Cells 
staining positive for EdU within 400μm of the tail tip were counted as well as cells 
staining positive for DAPI within the same area. A proliferative index was calculated 
as the ratio of EdU positive cells over DAPI positive cells. For cryo-section staining, 
trypsinization and the ice-cold acetone wash were skipped. Results were analyzed in 
GraphPad Prism software version 6.0 using one-way ANOVA.  
 
5.3.5 Cell orientation and cell density measurements. 
Cell orientation was measured using two-dimensional confocal imaging of fixed 
tissue. The orientation of DAPI-stained nuclei of mesodermal cells was determined 
relative to the forelimb bud epidermis. This was quantified as an angle by drawing a 
line through the longitudinal axis of each nucleus and relating this line to a line drawn 
parallel to the forelimb bud epidermis. There are several caveats of this approach for 
determining cell orientation, and thus the results should be considered as preliminary 
pending in vivo imaging using intracellular landmarks to determine the polarity of 
cells and transgenes that reveal cell membranes (Wyngaarden et al. 2010). Cells with 
nuclear angles were arbitrarily binned into 0-30, 30-60, or 60 to 90 degrees categories, 
for DMSO treated and Wnt-C59 treated embryos. Three progress zones were also 
arbitrarily defined to delineate proximal, middle, and distal regions of the forelimb 
bud. Cell numbers per 2500 µm2 were counted in each progress zone. Results were 
analyzed in GraphPad Prism software version 6.0 using one-way ANOVA.  
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5.4 Results 
5.4.1 Wnt signaling is required around developmental stage 40 for axolotl forelimb 
bud development.  
The axolotl tail amputation assay was previously performed during the time that 
embryos initiate forelimb development from developmental stage 40 to stage 44. I 
anecdotally observed that Wnt-C59 treatment inhibited forelimb bud outgrowth. I 
confirmed these observations by treating developmental stage 40 embryos with Wnt-
C59 or DMSO as controls, with eight embryos in each group. At stage 51, all eight 
control embryos presented limbs that were in the process of digit formation. A deep 
interdigital notch was observed between digits II and III, and a small indentation 
separated digits I and II. In comparison, Wnt-C59 embryos did not form forelimbs; 
representative images are shown in Figure 5.2 A and B. To determine if there is a 
critical window within which Wnt-C59 blocks forelimb development, I varied the 
time of dosing (Figure 5.1). Developmental stage 40 embryos that were treated with 
Wnt-C59 for the first three days of the experiment did not form forelimbs; this 
treatment also decreased the size of hindlimbs (Figure 5.2). All other treatment groups 
had well-developed forelimbs and hindlimbs. These results show that Wnt signaling is 
required at developmental stage 40 for axolotl forelimb development. 
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Figure 5.1. Wnt signaling is required at developmental stage 40 for axolotl forelimb 
development.  A total of 155 embryos at stage 40 were used. Each group had five 
animals. There were 30 treatment groups, and each of these groups was treated with 
10μM Wnt-C59 for three days with an overlapping series of treatments throughout the 
time course of forelimb development.  There was one control group treated with 0.1% 
DMSO at day 1 to day 3. Only a narrow window from day 1 to day three was 
associated with Wnt-C59 inhibition of forelimb development. 
  
5.4.2 Long-term phenotype of the Wnt-C59 treated animals 
I treated developmental stage 40 embryos with 0.1% DMSO or Wnt-C59 for three 
days and then reared the embryos to 1 year of age (Figure 5.2 C). Hindlimbs of 
embryos with continuous Wnt-C59 treatment from Day1-3 were significantly smaller 
and shorter than those of the controls (Figure 5.2 C-E, n=6, p < 0.01). These results 
show that Wnt-C59 prevents forelimb development and decreases the size of 
hindlimbs.  
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Figure 5.2. Wnt-C59 prevents forelimb bud development and decreases hindlimb size. 
White stippled lines outlined forelimbs. A) A DMSO treated embryo at 
developmental stage 51. B) Embryos treated with Wnt-C59 for the first three days did 
not form forelimbs. C) One-year-old adult axolotls treated with DMSO or Wnt-C59 as 
embryos. Left: The DMSO control animal had fully developed forelimbs and 
hindlimbs. Right: The Wnt-C59 treated animal had no forelimb, and smaller and 
shorter hindlimbs compared to DMSO controls. D) Wnt-C59 decreased hindlimb 
length. E) Wnt-C59 decreased the diameter of the hind limb at thigh level. *: p < 0.01 
for contrasts of DMSO control vs Wnt-C59. 
 
5.4.3 Down-regulation of Wnt3a expression by Wnt-C59 treatment is associated with 
inhibition of forelimb bud development. 
Limb bud outgrowth depends on signals emanating from the AER. Wnt3a is the 
earliest known AER marker during chick limb development. It signals through the 
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canonical β-Catenin pathway and mediates Fgf10 to induce Fgf8 expression in the 
limb ectoderm during AER formation (Kengaku et al. 1998; Kawakami et al. 2001). 
To investigate canonical Wnt signaling during axolotl forelimb bud development, I 
performed Wnt3a immunostaining using embryos that were treated with either DMSO 
or Wnt-C59. Embryos were treated for 72 hours after reaching developmental stage 
40 (the samples were collected at 72 hours after the treatment). There was no apparent 
AER observed during axolotl forelimb outgrowth. Wnt3a expression was higher in 
DMSO vs. Wnt-C59 treated embryos in the epidermis on D-V/P-D sections of the 
forelimb buds (Figure 5.3, p < 0.01, n = 6). Wnt3a did not appear to be differentially 
expressed among mesodermal cells of DMSO and Wnt-C59 treated forelimb bud, 
which suggests that the expression difference was specific to the epidermis.  
Assuming that the epidermis is 1-2 cells thick, Wnt3a expression was significantly 
higher on the apical side of epidermal cells in DMSO treated embryos (Figure 5.3, p < 
0.01, n = 6), and Wnt-C59 treatment significantly decreased Wnt3a expression 
(Figure 5.3, p > 0.01, n = 6). These data suggest that down regulation of Wnt3a 
expression by Wnt-C59 treatment is associated with inhibition of forelimb bud 
development.  
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Figure 5.3 Down-regulation of Wnt3a expression by Wnt-C59 treatment is associated 
with inhibition of forelimb bud development. All the samples were collected at 72 
hours after DMSO or Wnt-C59 treatment. The white stippled lines outlined forelimb 
buds. A-A’’) DMSO control forelimb bud stained for Wnt3a in red. Nuclei DNA was 
labeled by DAPI in blue. B-B’’) Forelimb treated with Wnt-C59 and stained for 
Wnt3a. C) Graph comparing Wnt3a expression between apical and basal sides of 
DMSO or Wnt-C59 treated forelimb buds, and Wnt3a expression between DMSO or 
Wnt-C59 treated forelimb buds at apical or basal sides of epidermal cells. *: p < 0.05 
for the contrast of basal vs apical side of the epidermis in DMSO controls, and DMSO 
control vs. Wnt-C59 for apical Wnt3a expression. Apical: Apical side of the 
epidermis. Basal: Basal side of the epidermis. 
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5.4.4 Polarity of mesodermal cells is disrupted by Wnt-C59 treatment. 
The early limb bud is described as an ectodermal bag of randomly arranged and 
uniformly distributed mesodermal cells (Lu et al. 2008). The elongation of the limb 
bud along the P-D axis is associated with polarized cellular behaviors (Gao and Yang 
2013). The Wnt/PCP pathway regulates oriented cell behaviors, which is very 
important for directional morphogenesis in developing limbs (Gao and Yang 2013). 
Zo1 expression is associated with planar cell polarity and is a component of tight 
junctions (Matter and Balda 2003). To determine if Wnt signaling affects the 
expression of Zo1, I compared Zo1 expression between DMSO and Wnt-C59 treated 
embryos. As was observed for Wnt3a, Zo1 expression was higher in apical epidermal 
regions of DMSO treated embryos, and Zo1 expression was significantly higher in 
DMSO vs. Wnt-C59 treated embryos (Figure 5.4 A-C, p < 0.01, n = 6). The 
orientation of mesodermal cell nuclei underlying the epidermis appeared to differ 
between DMSO and Wnt-C59 treated forelimb buds. The orientation of most 
mesodermal nuclei (relative to the epidermal plane) in DMOS treated embryos was 
greater than 60 degrees, while most of the nuclei in Wnt-C59 treated embryos were 
less than 30 degrees (Figure 5.4 A-D, p < 0.01, n = 9). Nuclei close to the epidermis 
of the forelimb bud were elongated and aligned to the epidermis perpendicularly in 
DMSO treated embryos. Nuclei, located in the center of the limb bud, showed no 
evidence of elongation and orientation. Mesodermal nuclei density was significantly 
higher in progress zone 3 compared with progress zones 1 and 2 in DMSO treated 
embryos (Figure 5.4 E, p < 0.01, n = 3). The density of nuclei differed significantly 
among all three progress zones in Wnt-C59 treated embryos (Figure 5.4 E, p > 0.01, n 
= 3). These results suggest that disruption of Wnt signaling by Wnt-C59 affects cell 
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orientation and density, and this is associated with a decrease in Zo1 expression in the 
epidermis. 
            
 
Figure 5.4 Planar cell polarity of forelimb mesodermal cells is disrupted by Wnt-C59. 
White stippled lines outlined forelimb buds. Cell counts and measures of cell 
orientation are based on the qualification of DAPI-stained nuclei. A-A’) DMSO 
control forelimb stained with Zo1. Nuclear DNA was labeled with DAPI. B-B’) 
Forelimb treated with Wnt-C59 and Stained with Zo1. C) Zo1 expression in the apical 
side of the epidermis of forelimb bud. D) Wnt-C59 disrupted the orientation of 
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mesodermal cell nuclei underlying the epidermis. E) Wnt-C59 altered cell density 
gradients at the P-D axis. p > 0.01). *: p < 0.05 for the contrast of basal vs. apical side 
in DMSO controls, or DMSO control vs. Wnt-C59 for apical Zo1 expression. α and β: 
representative angles between the longitudinal axis of mesodermal cell nuclei and a 
parallel line of drawn along the epidermal surface of the forelimb bud in DMSO or 
Wnt-C59 treated embryos. 1, 2, and 3: progress zone 1, 2, and 3. Blue arrows: 
representative mesodermal cell nuclei with angles more than 60° in DMSO treated 
embryos, and angles less than 30° in Wnt-C59 treated embryos. 
 
5.4.5 Wnt and Fgf signaling pathways promote cell progression at M-phase during 
forelimb bud outgrowth. 
Reiter and Solursh (1982) showed that the apical epidermis promotes mitosis of cell-
cultured, chick wing mesodermal cells. However, Pengfei Lu et al. (2008) showed 
that Wnt/β-Catenin signaling promotes survival of AER cells in the mouse limb, but it 
does not affect cell proliferation and survival of distal mesodermal cells. To determine 
if Wnt and Fgf signaling pathways affect cell mitosis during axolotl forelimb bud 
outgrowth, I stained forelimb tissues for a mitotic marker, phosphorylated histone H3. 
In DMSO control embryos, many mitotic cells were observed (Figure 5.5 A); the 
mitotic index of DMSO treated embryos was 18.2 ± 2.0% (Figure 5.5 C). Wnt-C59 
treatment reduced the mitotic index (9.2 ± 1.0%) significantly (Figure 5.5 A-C, p < 
0.01, n = 3). To take a closer look at mesodermal cells underlying the apical 
ectoderm, I performed phosphorylated histone H3 staining using cryo-sections across 
the forelimb bud at an A-P/P-D plane (Figure 5.5 G and H). The mitotic index in 
DMSO treated embryos was 5.0 ± 0.9%. Wnt-C59 treated embryos showed a reduced 
mitotic index 1.1 ± 0.5% (p < 0.01, n = 3). There were too few H3 positive cells to 
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determine if there was a proximal-distal mitotic gradient. H & E staining also showed 
that Wnt-C59 treatment decreased cell density in the forelimb bud (Figure 5.5 D-F, p 
< 0.01, n = 3).  
 
To further clarify that M-phase cell cycle progression of forelimb mesodermal cells is 
required for forelimb bud outgrowth, I treated embryos with an Fgf signaling pathway 
inhibitor because Fgf signaling is required for limb bud outgrowth (REF?). BGJ398 
decreased the mitotic index (11.1 ± 1.3%) relative to DMSO controls (18.2 ± 2.0%) 
(Figure 5.6 A-C, p < 0.01, n = 3). I also tested aurora kinase inhibitors that are known 
to regulate mitotic events (Marumoto et al. 2003). Three aurora kinase inhibitors, 
CYC116, MK-5108, and Danusertib, significantly inhibited forelimb bud outgrowth 
(Figure 5.7, p < 0.01, n = 4). These results show that Wnt signaling is required for 
mesodermal cell mitosis during axolotl forelimb bud outgrowth.  
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Figure 5.5. Wnt signaling supports the mitosis of forelimb mesodermal cells. A-B) 
DMSO control or Wnt-C59 treated forelimb field stained with phosphorylated 
Histone H3 using whole-mount samples. Mitotic cells were stained in red. Total DNA 
was stained with DAPI in blue. The white stippled line outlines the area within which 
Histone H3 positive or DAPI stained cells were counted to determine the mitotic 
index. C) Wnt-C59 treatment reduced the mitotic index of mesodermal cells of the 
forelimb. D-E) H&E staining of the right forelimb of DMSO or Wnt-C59 treated 
embryos. F) Wnt-C59 reduced mesodermal cell density in the forelimb buds. G-H) 
DMSO control or Wnt-C59 treated forelimb field stained with phosphorylated 
Histone H3 using cryo-sections. I) Wnt-C59 treatment reduced the mitotic index of 
mesodermal cells in the forelimb.  *: p < 0.05 for contrast DMSO control vs Wnt-
C59. 
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Figure 5.6 Fgf signaling supports the mitosis of forelimb mesodermal cells. A-B) 
Whole-mount phosphorylated Histone H3 staining for presumptive forelimb fields of 
DMSO or BGJ398 treated embryos. The images show mitotic cells stained in red. The 
total DNA was stained with DAPI in blue. The white stippled line areas were used to 
count phosphorylated Histone H3 positive or DAPI stained cells. C) BGJ398 
treatment reduced the mitosis index of the forelimb. *: p < 0.05 for contrast DMSO 
control vs BGJ398. 
                      
 
Figure 5.7 Aurora Kinase inhibitors inhibit forelimb bud outgrowth. The black 
stippled line outlines forelimbs of the embryos. A-D) Representative images showing 
embryos treated with DMSO, CYC116, MK-5108, and Danusertib. D) CYC116, MK-
5108, and Danusertib significantly halted forelimb bud outgrowth. *: p < 0.01 for 
contrasts DMSO control vs CYC116, MK-5108, or Danusertib. 
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5.4.6 Wnt signaling is critical for mesodermal cell proliferation in the forelimb bud. 
Cell proliferation is precisely controlled during embryonic development. Vertebrate 
limb bud morphogenesis depends upon regulated cell proliferation. A prominent 
hypothesis, the “proliferation gradient” model along the P-D axis, was proposed to 
explain how proliferation gradients engender limb bud outgrowth (Ede and Law 
1969). To test whether there is a proliferation gradient, and whether Wnt signaling 
plays a role in cell proliferation during forelimb bud outgrowth, cell proliferation was 
assayed at 72 hours post developmental stage 40 using EdU staining. To label 
proliferating cells, I delivered EdU at 48 hours post developmental stage 40. Wnt-C59 
treatment significantly reduced the cell proliferation index of forelimb bud 
mesodermal cells; the proliferation index was 52.8 ± 6.2% compared to 68.3 ± 3.8%) 
for the DMSO control (Figure 5.8 A, A’, B, B’, and D, p < 0.01, n = 6). However, cell 
proliferation did not differ between proximal and distal mesodermal cell populations. 
Thus, there does not appear to be a P-D proliferation gradient at this stage of axolotl 
limb bud development. Fgf signaling inhibitor BGJ398 also significantly decreased 
the cell proliferation index (BGJ398 vs DMSO control: 48.2 ± 12.2% vs 67.9 ± 3.8%, 
p < 0.01, n = 4) (Figure 5.8 A, A’, C, C’ and E). The proliferation index of Wnt-C59 
treated samples was lower than that of BGJ398 treated samples, but the difference 
was not statistically significant (p > 0.05, n = 4). These results show that Wnt 
signaling regulates mesodermal cell proliferation.  
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Figure 5.8 Wnt and Fgf signaling pathways regulate cell proliferation of mesodermal 
cells of the forelimb bud. EdU was injected 48 hours after treatment, and samples 
were collected 72 hours after treatment. Cryo-sections of D-V/P-D planes at forelimb 
bud levels were used for EdU staining. A) DMSO control forelimb bud stained with 
EdU. Proliferating cells were detected by EdU in green. Cell nuclei were labeled with 
DAPI in blue. A’) Detail image of A.  B) Forelimb treated with Wnt-C59 and stained 
with EdU. B’) Detail image of B. C) Forelimb treated with BGJ-398 and stained with 
EdU. C’) Detail image of C. D) Wnt-C59 reduced the cell proliferation index relative 
to the DMSO control. E) BGJ398 reduced the cell proliferation index relative to the 
DMSO control. *: p < 0.05 for contrasts DMSO control vs Wnt-C59 or BGJ398. 
 
5.5 Discussion 
In this chapter, I demonstrated the requirement of Wnt signaling pathways during 
forelimb bud outgrowth. Wnt and Fgf signaling pathways regulated cell proliferation 
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and mitosis of mesodermal cells during axolotl early forelimb bud outgrowth. 
Blocking the Wnt and Fgf signaling pathways reduced cell proliferation and mitosis 
of mesodermal cells, which are required for forelimb bud outgrowth. My results also 
suggest that cell orientation and cell density of forelimb bud mesodermal cells was 
disrupted by Wnt-C59 treatment. These differences between Wnt-C59 and control 
forelimb buds may trace to a disruption of Wnt-mediated patterning during forelimb 
bud outgrowth.  
 
Wnt3a expression altered by Wnt-C59 is associated with inhibition of forelimb 
bud outgrowth. 
Wnt3a is an early marker for the AER in chick (Kengaku et al. 1998; Kawakami et al. 
2001). Although I did not observe AER formation during axolotl forelimb outgrowth, 
I did observe that Wnt3a was highly expressed in the epidermis of a normally 
developing forelimb bud. Wnt-C59 altered Wnt3a expression and this was associated 
with inhibition of forelimb bud development. These results are consistent with ten 
Berge et al. (2008), who showed that Wnt3a cooperates with Fgf8 to maintain 
mesodermal cells in an undifferentiated, proliferative state to promote outgrowth of 
chick limb buds. This is the first study to suggest a role for Wnt3a in axolotl forelimb 
bud outgrowth.  
 
Reduced cell proliferation and mitosis by Wnt-C59 is associated with inhibition 
of forelimb bud outgrowth.  
Limb bud outgrowth relies on a continuous ectodermal-mesodermal interaction. 
Epidermal cells are necessary for controlling proliferation and mitosis (Lu et al. 
2008), and failure of communication between the ectoderm and mesoderm disrupts 
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limb development (Fernandez-Teran, Ros, and Mariani 2013). In this study, I found 
that about 5 percent of cells were mitotic in the forelimb bud in DMSO treated 
controls. Wnt and Fgf pathway inhibitors significantly reduced cell proliferation and 
mitosis of mesodermal cells. Ten Berge et al. (2008) reported that Wnt3a alone 
promotes the growth of chick limb mesenchyme in culture, while Fgf8 alone does not. 
However, Fgf8 synergistically enhances the proliferative effect of Wnt3a. It would be 
interesting to titer Fgf and Wnt signaling activities by varying the dosage of chemical 
inhibitors to determine if these pathways synergistically regulate cell proliferation and 
mitosis during limb development. It would also be interesting to investigate the aurora 
kinase inhibitors that were shown to inhibit limb regeneration in this study, as this 
might link Wnt signaling to a specific mitotic mechanism.   
 
The critical window for forelimb bud outgrowth  
I identified a narrow window around developmental stage 40 within which Wnt-C59 
blocked forelimb bud outgrowth. This suggests that the requirement for Wnt signaling 
during limb development has a distinct, offset timing. It seems reasonable to assume 
that the offset requirement for Wnt signaling coincides with systemic changes in 
signaling centers that regulate limb bud outgrowth. For example, a regulatory loop 
consisting of Wnt factors (Wnt3a, Wnt2b, and Wnt8c) and fibroblast growth factors 
(Fgf8 and Fgf10) regulates AER formation and limb bud outgrowth (Kawakami et al. 
2001). Wnt7a expression in non-AER limb ectoderm determines dorsal limb cell 
identity and dorsal-ventral axis regulation (Riddle et al. 1995). Wnt signaling around 
developmental stage 40 may coincide with these signaling mechanisms. 
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Applications for using the axolotl embryo model to identify chemicals that alter 
limb development and regeneration 
The discovery that Wnt-C59 inhibits limb development was serendipitous as it was 
discovered in a chemical genetic screen using a tail regeneration assay (Ponamareva 
et al 2015). Many chemicals discovered from this screening project provides tools for 
investigating mechanisms of tail regeneration (Voss et al 2019). The discovery of 
Wnt-C59 as an inhibitor of limb development suggests that this same axolotl 
screening platform can be used to identify chemicals for studies of limb development 
and regeneration. Additionally, the axolotl embryo assay could provide an efficient 
and cost-effective tool for screening chemical libraries for toxicity and limb 
developmental defects.   
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CHAPTER 6: SUMMARY AND DISCUSSION: SIGNALING PATHWAYS 
DURING AXOLOTL TAIL REGENERATION AND FORELIMB BUD 
OUTGROWTH 
 
Signaling pathways and axolotl tail regeneration  
Signaling pathways are activated by injury-induced cytokines, growth factors, and 
local activators during regeneration. The axolotl tail regeneration model provides an 
excellent tool to investigate signaling pathways during tissue regeneration. The 
axolotl embryo is capable of regenerating an amputated tail in about seven days. 
Using this model, Ponomareva et al. (2015) identified three chemicals inhibitors 
(SB505124, Wnt-C59, and BGJ398) of Tgf-β, Wnt, and Fgf signaling pathways that 
blocked axolotl tail regeneration. The purpose of my dissertation was to study these 
chemical inhibitors in more depth as the results might guide progress in understanding 
mechanisms of regeneration, and ultimately cellular reprogramming and tissue 
engineering toward repairing complex body parts in mammals. 
 
Disruption of major signaling pathways reduces cell mitosis and cell 
proliferation. 
In my model, axolotl tail regeneration initiates after amputation of 2mm of the distal 
tail tip. The amputation injury is thought to induce typical innate immune responses, 
including clotting, immune cell activation, and cell death. Within 1 hour, a simplified 
epithelium forms over the exposed tail stump. Underneath the epidermis, progenitor 
cells from different tissues organize in the tail tip and form a regenerating bud. In 
chapter 2, 3 and 4, I showed that inhibition of Tgf-β, Wnt, or Fgf signaling pathways 
by SB505124, Wnt-C59, or BGJ398 yielded decreased cell proliferation and mitosis 
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in several tissue types including spinal cord, dorsal fin, ventral fin, and distal tail tip 
(Table 6.1). However, the Fgf signaling pathway inhibitor BGJ398 did not 
significantly affect cell proliferation in the spinal cord. Upon Fgf inhibitor release, the 
tail regeneration process re-initiated and went to completion.  It is thought that Fgfs 
are morphogens that support progenitor cell proliferation. My results show that signal 
pathway inhibition can affect tissues differently and a cell proliferation response is not 
sufficient for regeneration. For example, Naringenin inhibited tail regeneration but not 
the cell proliferation response (Table 6.1). It seems likely that signaling pathways 
synergistically and cooperatively control cell proliferation during axolotl tail 
regeneration. In the future, it will be important to test for synergistic and cooperative 
effects of inhibitors to determine how pathways interact to regulate cell proliferation 
and mitosis.  
 
Table 6.1 Inhibitors of cell proliferation and mitosis. 
 Target Signaling 
pathway 
Cell mitosis Cell 
proliferation 
SB505124 Alk4/5/7 Tgf-β ↓ ↓ 
Naringenin  p-Smad3 Tgf-β - NS 
Wnt-C59 Porcupine Wnt ↓ ↓ 
BGJ398 Fgfr1/2/3 Fgf ↓ ↓ but not the 
spinal cord 
✓: Expressed; ↑: Increased; ↓: Decreased; NS: Non-significant; -: Not done. 
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Ligands may induce transcriptional changes that jointly regulate Tgf-β, Wnt, 
and Fgf signaling. 
I found that Tgf-β1 was up-regulated during axolotl tail regeneration. Upregulation of 
Tgf-β1 was similarly found during tadpole tail regeneration (Denis et al. 2016; 
Levesque et al. 2007). In my studies, I used Tgf-β pathway inhibitor SB505124, 
which inhibits Alk5, Alk4, and Alk7 type I receptors. It seems plausible that Tgf-β1 
acts through one or more of these receptors to orchestrate axolotl tail regeneration. 
However, other Tgf-β pathway ligands could be important. For example, Inhbb 
transcripts were decreased at 24hpa upon Wnt pathway inhibition (Ponomareva et al. 
2015). Inhbb shares a β subunit with Activin, and its function is thought to oppose 
Activin (Zhu et al. 2012; Namwanje and Brown 2016).  
 
In contrast to increasing Tgf-β1 levels during regeneration, Wnt3a was decreased at 
24 and 72hpa in the regenerating tail. While this suggests down-regulation of some 
Wnt pathway activities, other Wnt ligands (that were not quantified in my study) may 
activate Wnt signaling during tail regeneration. For example, Wnt-C59 treatment 
caused a significant decrease in Wnt5a transcription at 24, 48, 72, and 120hpa, 
suggesting a requirement for Wnt5a during later stages of regeneration, when the rate 
of tissue outgrowth increases (Ponomareva et al. 2015). Additionally, Wnt-C59 
treatment significantly decreased Fgf9 transcription at 24hpa, and then later between 
72-120hpa (Ponomareva et al. 2015). As discussed above, Inhbb may function to 
oppose Activin and upregulate Tgf-β signaling. Tgf-β signaling appears to act 
upstream of Wnt signaling, which in turn up-regulates and positively feeds back on 
Tgf-β signaling. In future studies, it will be essential to investigate the crucial roles of 
Wnt5a during axolotl tail regeneration by creating an axolotl Wnt5a knock-out 
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predicted to show decreased expression of Fgf9 and Inhbb at 24 hpa, and inhibited 
regeneration. This would potentially identify a transcriptional network that jointly 
regulates Tgf-β, Wnt, and Fgf signaling pathways (Figure 6.1).  
 
 
Figure 6.1 Crucial ligands regulate Tgf-β, Wnt, and Fgf signaling pathways. 
 
SB505124 and Naringenin differentially affect early Smad mediated TGF-β 
signaling. 
In chapter 2, I showed that chemical disruption of Tgf-β signaling altered Smad 
mediated Tgf-β signaling pathway components. In regenerating tails, both Smad2 and 
Smad3 were activated upon tail amputation as early as 1hpa. p-Smad2 steadily 
increased afterward at the tested time points while p-Smad3 decreased. Application of 
SB505124 down-regulated both p-Smad2 and p-Smad3 at all post-amputation time 
points and blocked tail regeneration. Naringenin also down-regulated p-Smad2 at all 
post-amputation time points, delayed peak p-Smad3 expression, and completely 
blocked tail regeneration. However, SB505124 treatment affected p-Smad2 at an 
earlier time and to a greater degree than p-Smad3, while Naringenin affected p-Smad3 
at an earlier time and to a greater degree than p-Smad2 (Table 6.2). The opposing 
roles played by Smad2 and Smad3 have been studied during both embryo 
development and tissue regeneration. The differential regulation of p-Smad2 and p-
Smad2 may lead to differences in progenitor cell proliferation and mitosis. Further 
fgf9 wnt5a Inhibin 
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studies are needed to understand the different requirements for Smad2 and Smad3 
signaling and their role in regulating cell proliferation and mitosis during axolotl limb 
and tail regeneration.  
 
Table 6.2 SB505124 and Naringenin differentially affect Smad-mediated TGF-β 
signaling. 
 DMSO SB505124 vs 
DMSO 
Naringenin vs 
DMSO 
p-Smad2 at 0hpa ✓   
p-Smad2 at 1hpa  ↑ ↓↓↓ ↓ 
p-Smad2 at 6hpa ↑ ↓ ↓ 
p-Smad2 at 12hpa ↑ ↓ ↓ 
P-Smad3 at 0hpa ✓   
p-Smad3 at 1hpa ↑ NS ↓↓↓ 
p-Smad3 at 6hpa ↓ ↓ ↑ 
p-Smad3 at 12hpa ↓ ↓ NS 
✓: Expressed; ↑: Increased; ↓: Decreased; ↓↓↓: Decreased more than the other 
chemical; NS: Non-significant. 
 
Inhibition of Tgf-β, Wnt, or Fgf signaling pathways alters phosphorylation of 
Erk and Akt. 
I found that p-Erk and p-Akt responded to tail amputation at an early phase of tail 
regeneration. P-Erk was expressed at the time of tail amputation, increased at 1hpa 
and then decreased at 6hpa. P-Akt was expressed at the time of tail amputation; it 
changed very little at 1hpa and decreased at 6hpa. Overall, increased expression of p-
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Erk and decreased expression of p-Akt appear to be important early signaling 
responses. Furthermore, p-Erk and p-Akt were significantly up-regulated in 
SB505124-treated tails, but significantly down-regulated in Naringenin-treated tails at 
1hpa; thus, p-Erk and p-Akt were affected by disruptions of Tgf-β signaling (Table 
6.3). Moreover, Wnt and Fgf signaling pathways regulated phosphorylation of Erk 
and Akt. In chapter 3, I found that disruption Wnt signaling pathway by Wnt-C59 
increased phosphorylation of Erk at 48hpa and phosphorylation of Akt at 48 and 
72hpa. In chapter 4, I found that disruption of Fgf signaling by BGJ398 down-
regulated p-Erk and p-Akt. Overall, all three signaling pathways affected the 
phosphorylation of Erk and Akt; pathways are known to regulate cell proliferation, 
cell survival, and cell fate specification (Table 6.4). Future studies are needed to 
determine if changes in Erk and Akt phosphorylation affect cell proliferation and 
mitosis, as well as the regenerative outcome in axolotl embryo model. 
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Table 6.3 SB505124 and Naringenin differentially affect non-Smad mediated TGF-β 
signaling. 
 DMSO SB505124 vs 
DMSO 
Naringenin vs 
DMSO 
p-Erk at 0hpa ✓   
p-Erk at 1hpa ↑ ↑ ↓ 
p-Erk at 6hpa ↑ ↑ NS 
  p-Erk at 12hpa ↑ ↓ NS 
    p-Akt at 0hpa ✓   
p-Akt at 1hpa NS ↑ ↓ 
p-Akt at 6hpa ↓ NS ↓ 
  p-Akt at 12hpa ↓ NS ↓ 
✓: Expressed; ↑: Increased; ↓: Decreased; NS: Non-significant. 
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Table 6.4 Effects of Wnt-C59 and BGJ398 on Erk and Akt signaling. 
 DMSO Wnt-C59 vs DMSO BGJ398 vs 
DMSO 
p-Erk at 0hpa ✓   
p-Erk at 24hpa  NS NS NS 
p-Erk at 48hpa ↓ ↑ ↓ 
p-Erk at 72hpa ↑ NS NS 
p-Akt at 0hpa ✓   
p-Akt at 24hpa  ↓ NS NS 
p-Akt at 48hpa NS ↑ ↑ 
p-Akt at 72hpa NS ↑ ↑ 
✓: Expressed; ↑: Increased; ↓: Decreased; NS: Non-significant. 
 
Inhibition of Wnt or Fgf signaling pathways affects Wnt/β-Catenin signaling. 
In chapter 3, I found that β-Catenin was decreased at 48hpa and increased at 72hpa 
relative to 0hpa during axolotl tail regeneration. Wnt-C59 treatment increased β-
Catenin at 48hpa. In chapter 4, I found that BGJ398 treatment increased Wnt3a 
expression at 48hpa and 72hpa; it also increased β-Catenin at 48hpa (Table 6.5). 
These data suggest that some Fgf signaling activities are inversely correlated with 
Wnt/β-Catenin signaling. 
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Table 6.5 Effects of Wnt-C59 and BGJ398 on Wnt3a and β-Catenin expression. 
 DMSO Wnt-C59 vs. 
DMSO 
BGJ398 vs. 
DMSO 
Wnt3a at 0hpa ✓   
Wnt3a at 24hpa  ↓  NS 
Wnt3a at 48hpa NS  ↑ 
Wnt3a at 72hpa ↓  ↑ 
β-Catenin at 0hpa ✓   
β-Catenin at 
24hpa  
NS NS NS 
β-Catenin at 
48hpa 
↓ ↑ ↑ 
β-Catenin at 
72hpa 
↑ NS NS 
✓: Expressed; ↑: Increased; ↓: Decreased; NS: Non-significant. 
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Figure 6.2 Preliminary network for Tgf-β, Wnt, and Fgf signaling pathways during 
axolotl tail regeneration. Red arrows show how chemicals increased expression of 
signaling components. Blue arrows show how chemicals decreased expression of 
signaling components. The numbers report the earliest times (hours post amputation - 
hpa) at which signaling components were affected. 
 
Wnt3a is an essential ligand for forelimb bud outgrowth. 
Wnt3a is known to mediate canonical Wnt/β-Catenin signaling and is an early marker 
of the AER in amniote vertebrate limbs (Kengaku et al. 1998; Kawakami et al. 2001). 
In chapter 5, I detected Wnt3a expressed in the epidermis of the developing forelimb 
bud. Wnt-C59 altered Wnt3a levels and expression patterns in the limb and prevented 
forelimb bud outgrowth. To my knowledge, this is the first study analyzing Wnt3a 
ligand in axolotl forelimb bud outgrowth. The Wnt3a expression pattern in the 
epidermis during axolotl limb development maybe characteristic of non-amniote 
vertebrate limb development. My results suggest a role for Wnt3a in forelimb bud 
outgrowth in the axolotl but do not rule out essential roles for other Wnt ligands. For 
example, Wnt2b-Wnt8c/β-Catenin signaling in the lateral plate mesoderm is vital for 
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Fgf10 expression in the mesenchyme of the presumptive chick limb bud (Kawakami 
et al. 2001). Also, Wnt5a regulates limb bud initiation by controlling asymmetric cell 
behaviors (Gao and Yang 2013; Wyngaarden et al. 2010; Gros et al. 2010). 
 
Planar cell polarity in epidermal cells and underlying mesodermal cells is 
associated with proximal-distal axis elongation. 
In chapter 5, I showed that Wnt signaling pathway inhibition altered the expression of 
Wnt3a and Zo1 in epidermal cells, appeared to affect the polarity of mesenchymal 
cells, and blocked forelimb bud outgrowth. The first definitive demonstration of PCP 
during limb development was established by showing symmetrical localization of 
Vangl2 in newly formed mesenchymal cells along the proximal-distal limb axis of 
mice (Gao et al. 2011). In Wnt5a knockout mice, limb elongation is impaired (Gros et 
al. 2010). Future studies are needed to rigorously document changes in cell polarity 
that would establish Wnt/PCP signaling in the developing axolotl forelimb.  
 
 Wnt and Fgf signaling pathways regulate cell proliferation and mitosis of limb 
mesodermal cells. 
Continuous ectodermal-mesodermal interaction is important for limb bud outgrowth. 
Epidermal cells of the limb bud are necessary for controlling cell proliferation and 
mitosis during forelimb outgrowth (Lu et al. 2008). In Chapter 5, the developing 
axolotl forelimb bud was shown to contain a high number of mitotic cells. Both Wnt-
C59 and BGJ398 reduced mesodermal cell proliferation and mitosis. Thus, Wnt and 
Fgf signals are essential to maintain the function of the apical epidermis as an inducer 
of cell proliferation and mitosis in underlying mesodermal cells. To further confirm 
that cell mitosis is necessary for successful forelimb bud outgrowth, I showed that 
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three different aurora kinase inhibitors CYC116, MK-5108 (VX-689), and Danusertib 
halted forelimb bud outgrowth, to different degrees. Thus, the proper amount of cell 
mitosis is required for forelimb bud outgrowth. It would be interesting to find a direct 
link between Wnt signaling and aurora kinases during axolotl forelimb bud 
outgrowth. Overall, Wnt and Fgf signaling pathways play essential roles in regulating 
cell proliferation and mitosis to assure forelimb bud outgrowth. 
 
The critical window for forelimb bud outgrowth 
In Chapter 5, a critical narrow window around developmental stage 40 was found 
during which Wnt-C59 completely blocked forelimb bud outgrowth, thus suggesting a 
distinct, offset timing for Wnt signaling to regulate limb development. It appears that 
the offset requirement for Wnt signaling coincides with more systemic changes in 
signaling centers that regulate forelimb bud outgrowth. For example, a regulatory 
loop consisting of Wnt factors and the fibroblast growth factors regulates AER 
formation and limb bud outgrowth (Kawakami et al. 2001). Wnt7a expression in non-
AER limb ectoderm determines dorsal limb cell identity and thus dorsal-ventral axis 
regulation (Riddle et al. 1995). Wnt signaling around developmental stage 40 may 
relate to systemic signaling changes in signaling centers that regulate forelimb bud 
outgrowth. 
 
In summary, this dissertation examined the requirements of Tgf-β, Wnt, and Fgf 
signaling pathways during axolotl tail regeneration and the requirement of Wnt 
signaling during axolotl forelimb bud outgrowth. Tgf-β, Wnt, and Fgf signaling 
pathways are required during axolotl tail regeneration. Inhibition of all three pathways 
affects Erk and Akt signaling pathways, and cell proliferation and mitosis. The Wnt 
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signaling pathway is required for forelimb bud outgrowth, and failure to develop 
forelimbs is associated with altered Wnt3a and Zo1 expression and decreased cell 
proliferation and mitosis. These data enrich understanding of signaling pathway 
network dynamics that underlie tissue regeneration and vertebrate limb development.  
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